EMT (Emerging Medical Technologies) Database

EMT (Emerging Medical Technologies) Database published by Life Science Intelligence, Inc.. This annual information service price starts from US $ 499.

Introduction

Abstract

The Emerging Medical Technologies (EMT) Database is an online tool for strategic marketing, market research, business development and investment executives seeking discreet and detailed business, market, and competitive intelligence on privately-held companies developing disruptive technologies.

This database currently includes 1101 companies and includes regular updates.

LSI leverages multiple, exclusive data streams to feed this robust database, including:

• An exclusive license to record the presentations and executive summaries for presenting companies at the prestigious annual Medtech Insight/Elsevier In3 West, In3 East, In3 Medical Device Summit, and In3 Europe meetings (approximately 130 companies per year)
• CEO presentations and executive summaries from LSI' s quarterly EMT Spotlight meetings (approximately 130 companies per year)
• Ongoing in-house research efforts (approximately 140 companies per year)

You get access to existing content, database additions, and updates for the duration of your subscription.

This database is the premier tool for identifying, tracking, partnering with, investing in, or reacting to, emerging companies in the space.

Highlights:

• 1101 Companies to Date
• + Regular Updates
• Coverage through 2011

Company Overviews:

Data includes:

• Key Executive
• Financing Status and Needs
• Revenue
• Development Status
• Strategic Partnering Needs
• Contact Info
• Year Established
• Website
• + More

Executive Summaries:

Data includes:

• Company Overview (structure, size, year founded, etc)
• Technology Details
• Target Markets
• Competitive Landscape and Differentiation
• Financial Summary and Sales Forecasts
• Financing & Partnering Needs
• IP Position & Status
• Management Team Overview
• + More

CEO Presentations:

Data includes:

• 10-15 minute slides and corresponding audio
• Investor/Partner/Business related content -- not product demos or infomercial style videos readily available in the public domain
• Coverage of all past and future IN3 Conferences

Companies:

In addition to the companies covered on the In3 conference circuit, we reveal new companies to you via our active in-house research efforts and quarterly EMT Spotlight meetings.

Technology descriptions for companies currently covered as of 04/26/10 include:

• Company 1 - A non-invasive diagnostic medical device that replaces the current traumatic procedure used to detect pediatric VUR (urinary reflux) and prevent kidney damage in 4M children annually
• Company 2 - Highly differentiated aorto-ostial stent and delivery platform for both peripheral and coronary applications
• Company 3 - Medical records application on a simple USB flash drive for patients, providers, and insurers
• Company 4 - Intelligent orthopedic devices that will address the growing clinical and economic cost of orthopedic implant failure and osteoporosis
• Company 5 - Occlusion device which provides men seeking a permanent form of contraception with a less-invasive alternative to vasectomy
• Company 6 - Minimally invasive lumbar annular repair technologies to prevent disc re-herniation and interrupt disc degeneration
• Company 7 - Web-based service platform, enabled by an imaging technology, for the remote evaluation of skin cancer
• Company 8 - Device to non-invasively detect and quantify cancer cells in the blood flow with fluorescent probes and WITHOUT blood sampling
• Company 9 - Products ranging from needleless injection site connectors, to safety syringes, and biodiagnostic sampling devices
• Company 10 - Products for the urinary incontinence market
• Company 11 - New medical diagnostic system for the early detection of lung cancer
• Company 12 - New method of treating open angle glaucoma using a non-invasive ultrasound device
• Company 13 - Technology aimed at advances in micro-laparoscopic surgery that improves hand-eye coordination and reduces the number of surgical incisions by at least one port
• Company 14 - Varicose vein stripping under direct vision for ablation of the diseased saphenous vein in a kit that reduces trauma, minimizes bleeding, and expects improved clinical outcomes
• Company 15 - Electronic biofeedback stimulation device that analyzes as well as treats
• Company 16 - Selective cytopheresis-based, modulating system to address inflammation-based diseases and conditions
• Company 17 - Technology that bridges the gap between low-tech aspiration and complex electromechanical aspiration systems for use in thrombus removal, rotational vacuum assisted biopsy, tissue resection, and spinal disc decompression
• Company 18 - Medical device for the symptomatic treatment of rhinitis (allergies)
• Company 19 - Next-generation biologic devices for high-volume hemorrhage and sepsis
• Company 20 - Minimally invasive device for midface lift and other lift procedures
• Company 21 - Robotic ankle and foot prosthesis
• Company 22 - Handheld CD4 cell counter
• Company 23 - Auto-adjusting portable oxygen system
• Company 24 - Magnetically-guided enteral feeding tube
• Company 25 - Wireless electrocardiography
• Company 26 - Human fibrinogen-based tissue sealant
• Company 27 - Gastrointestinal endoscopy products
• Company 28 - Interventional cardiology devices for chronic total occlusions
• Company 29 - Dental imaging
• Company 30 - Type 1 Diabetes medication delivery
• Company 31 - Transdermal therapeutics for neurological and psychiatric diseases
• Company 32 - In-situ formed hydrogels for radiation oncology and oncologic surgery
• Company 33 - Protein signature-based diagnostic tests for prostate, lung, and breast cancers
• Company 34 - Synthetic polymer for osteoarthritis therapy
• Company 35 - Controlled warm air delivery device for human head lice removal
• Company 36 - Polymolecular system for the treatment of inflammatory disease
• Company 37 - Critical care monitoring technologies
• Company 38 - Advanced feeding tube technology which can be placed using ultrathin endoscopes
• Company 39 - Home healthcare device for use by patients to self-measure Intraocular Pressure (IOP)
• Company 40 - Ultrasonic technologies and related techniques for aesthetic surgery
• Company 41 - Therapeutic ultrasound to treat hypertension
• Company 42 - Breast imaging system for early breast cancer detection
• Company 43 - RFID technology and software systems for medical device manufacturers, distributors, and hospitals
• Company 44 - Smart card platform that identifies and authenticates a patient to the healthcare provider and matches the patient to his or her medical record
• Company 45 - "Lap-Pak" is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site while eliminating the need for re-positioning during surgery
• Company 46 - Enhanced meter dose inhalers and spacer devices for the treatment of Asthma and COPD
• Company 47 - Sensor-based, video-monitored, automatic/semi-automatic laryngoscope that makes intubation easy, safe, and fast
• Company 48 - Point-of-care automated optical diagnostic device for platelet quality testing
• Company 49 - Portable diagnostic device used to determine the presence and level of Myocardial Ischemia (MI)
• Company 50 - Suite of diagnostic imaging products using near-field and forced-resonance principles targeting several specialties including cardiology, oncology, orthopedics, and neurology
• Company 51 - Rapid endovascular vessel occlusion and blood flow interruption
• Company 52 - Flat panel and custom radiation sources that solve problems in sterilization and medical imaging
• Company 53 - Non-invasive, easy-to-use device that uses pulsed radio frequency energy (PRFE) for tissue growth, wound healing, and pain relief
• Company 54 - Robotic assistance device for CT-guided soft tissue interventions
• Company 55 - Fatigue-resistant/fiber-reinforced bone cement for orthopedic joint replacement
• Company 56 - Full line of products specifically dedicated to avoiding a total joint replacement and preserving the shoulder, hip, knee, or ankle joints
• Company 57 - Single-use, disposable silver ion delivery device to treat Osteomyelitis (OM)
• Company 58 - Miniature/high-resolution/low-cost CMOS (complimentary metal-oxide semiconductor) image sensors for use in disposable endoscopic surgical applications
• Company 59 - Fish-skin-derived tissue regeneration technology for use in a range of reconstructive and orthopedic surgical procedures
• Company 60 - Hand-held ultrasound device that displays the image in the medical practitioner' s line of sight, at the patient' s skin surface
• Company 61 - Minimally invasive ultrasound-guided RF ablation system to treat symptomatic uterine fibroids through a transcervical approach
• Company 62 - Device that creates a reliable anastomosis to any graft site, for use in CABG and vascular surgeries
• Company 63 - Rapid/sensitive/cost-effective diagnostic products for detecting microbes causing hospital associated infections
• Company 64 - Diagnostic products for rapid infection determination at the point-of-care (POC) for professional and consumer markets
• Company 65 - Cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system
• Company 66 - POC/PST device to directly detect clot formation and do it in real time
• Company 67 - 1-Low-cost, disposable point-of-care (POC) Pap smear replacement requiring no lab or medical professional; 2-Drug-eluting contraceptive cervical barrier
• Company 68 - Small/wearable/all-mechanical insulin delivery device containing a 3-day supply of insulin
• Company 69 - Transformative device for detecting and treating breast cancer
• Company 70 - Stand-alone/rapid/autologous cell harvesting processing and delivery technology
• Company 71 - System that measures airway inflammation to determine asthma severity for improved treatment
• Company 72 - Minimally invasive, image-guided therapies to treat back pain
• Company 73 - Products enhancing focally-delivered radiation and drug therapies for patients with spinal metastatic disease or bone tumors
• Company 74 - Needle-free drug delivery for migraine attacks and cluster headache episodes
• Company 75 - Image-guided ultrasound for prostate cancer tissue ablation
• Company 76 - Obstetric position tracker and ultrasound technology
• Company 77 - Compact ultrasound devices
• Company 78 - Continuous blood glucose measurement devices
• Company 79 - Radiosurgical therapy for neurovascular and inflammatory ocular conditions
• Company 80 - Wound closure technology
• Company 81 - Neurosurgical tumor removal
• Company 82 - Surgical device for treating benign prostatic hyperplasia (BPH) and other conditions
• Company 83 - Endovascular technology to treat peripheral atherosclerosis in the superficial femoral and popliteal arteries
• Company 84 - Spine arthroplasty products
• Company 85 - Implants for sensorineural hearing loss
• Company 86 - Medical textiles for hemostasis
• Company 87 - 1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access through the intraosseous space for the delivery of essential drugs and fluids, 3-System for aspirations, biopsies, and stem cell collections
• Company 88 - Pressure cycling technology (PCT) to safely, conveniently, and reproducibly control the actions of molecules in biological samples
• Company 89 - Low-cost technology to survey the genome in its native state, in context, and at ultra-high resolution, without the need for DNA amplification
• Company 90 - Temperature management technology to treat hyperthermia and hypothermia, prevent damage from stroke, and enhance cancer therapies
• Company 91 - Optical technology for correcting presbyopia
• Company 92 - Non-invasive radiofrequency (RF) energy-based system to treat vaginal stretching caused by childbirth
• Company 93 - High-quality, cost-efficient, single-room proton beam radiotherapy (PBRT) system as an alternative to conventional high-energy x-rays
• Company 94 - Controlled, targeted deep-tissue therapeutic warming system to promote pain relief, reduce joint stiffness, and enhance recovery/rehabilitation programs
• Company 95 - 1-Artificial larynx, 2-Ear, nose, and throat (ENT) prostheses/implants
• Company 96 - microRNA-based tests to diagnose various cancers and gastrointestinal diseases
• Company 97 - Brain training software aimed at enabling individuals to strengthen cognitive function using the concept of neuroplasticity
• Company 98 - Non-invasive near-infrared (NIR) laser energy for the treatment of: acute ischemic stroke, spinal cord injury, traumatic brain injury, global cerebral ischemia, spinal cord injury, Alzheimer' s disease, Parkinson' s disease, and sepsis
• Company 99 - Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmology as well as cardiology, urology, and tissue engineering
• Company 100 - Advanced polymer-based biomaterials for applications in cardiology, dentistry, orthopedics, surgery, and urology
• Company 101 - Neurostimulation device to block residual limb pain caused by complications of amputations, as well as chronic pain after surgery, and migraine pain
• Company 102 - Joint, spine, and trauma implants
• Company 103 - "Minimally invasive" gene repair
• Company 104 - Implantable device for the surgical treatment of obesity without reliance on sutures, staples, or other mechanisms that puncture the stomach wall
• Company 105 - Microdermabrasion system with polyester/nylon bristle tips and variable vacuum levels for particle-free/crystal-free performance
• Company 106 - Elastic, self-expanding devices to specifically improve left ventricle relaxation and diastolic function
• Company 107 - Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an inexpensive, portable, and easy-to-use configuration
• Company 108 - Routine serum DNA blood tests for early cancer diagnosis and management
• Company 109 - Minimally invasive alternative to the surgical treatment of obesity
• Company 110 - Drug-eluting balloons that allow for controlled release of different and even multiple substances, for the treatment of coronary (CAD) and peripheral artery disease (PAD)
• Company 111 - Cancer prognostic tests for predicting specific individual patient clinical outcomes
• Company 112 - Genomics-based in vitro diagnostic (IVD) tests developed from FFPE tissue for personalized medicine
• Company 113 - Needleless/transdermal delivery system for insulin, analgesics, or vaccines with on/off control of dosing
• Company 114 - MRI-compatible ultrasound applicator to deliver controlled thermal therapy to the cancerous regions of the prostate gland
• Company 115 - Non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system
• Company 116 - Antimicrobial solutions to reduce the incidence of Surgical Site Infections (SSIs) in spinal surgeries
• Company 117 - Tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself
• Company 118 - Catheter-based system to treat large vessel acute ischemic strokes
• Company 119 - Next-generation remote patient monitoring (RPM) to continuously monitor vital life-sign functions such as: heart rate, respiratory rate, body position, activity level, and skin temperature
• Company 120 - Total Artificial Heart (TAH) to replace both ventricles of a failed heart, thus, restoring the circulatory system to normalcy
• Company 121 - Articulating range-of-motion (ROM), non-surgical spinal decompression system to treat herniated, bulged, and injured discs
• Company 122 - Portable DNA analyzers for on-demand, non-batched testing, with real-time polymerase chain reaction (PCR) results in 30-60 minutes
• Company 123 - Biomimetic hydrogel implants for spine and other orthopedic applications
• Company 124 - System designed to prevent contrast-induced nephropathy (CIN)
• Company 125 - Computer-Aided Diagnosis (CADx) tool for personalized, objective diagnosis and treatment management of musculoskeletal diseases
• Company 126 - NuOrtho Surgical, Inc. is a highly innovative early stage medical device company developing revolutionary technology for the healthcare industry. Our focus is to preserve the normal, healthy tissue of patients that today is damaged as a by-product of current treatments.
• Company 127 - Ventricular Assist Device (VAD) that can be inserted above the diaphragm
• Company 128 - Handheld, non-invasive, real-time Central Venous Pressure (CVP) monitor for cardiology and nephrology diagnostic applications
• Company 129 - Next-generation stent platform with: significantly thin walls for reduced restenosis, ease-of-use, superior deliverability, and improved radiopacity for accurate placement
• Company 130 - In-line, battery-powered, disposable, lightweight, and completely portable blood and IV fluid warming device, capable of intravenous application and irrigation warming
• Company 131 - Next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products/procedures to improve patient outcomes without adding to procedure time/cost
• Company 132 - Digital fluorescence scanners for molecular pathology research, biomarker development, and clinical molecular diagnostics (MDx) for personalized medicine
• Company 133 - Technology to enable home healthcare providers to provide better patient care while improving operational efficiency by 20-30%
• Company 134 - Polymer technologies for drug delivery and regenerative medicine with applications in orthopedics and spine
• Company 135 - A-FX(TM) is a minimally invasive platform technology for creating an orthopedic implant in-situ which provides superior fixation in osteoporotic bone
• Company 136 - Non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating postoperative pain and edema in superficial soft tissue
• Company 137 - Non-invasive reverse thermal gradient technology to treat conditions of tendons, ligaments, muscles, fasciae, and joints
• Company 138 - Automated cranial maxillo-facial (CMF) screw delivery system
• Company 139 - Non-invasive brain physiological measurement technologies
• Company 140 - Smallest/passive/implantable tag using RFID (radio-frequency identification) technology
• Company 141 - Diabetic pain relief via topical dermal administration and controlled release of pure Nitric Oxide (NO)
• Company 142 - Set of catheters for percutaneous isolation of an organ and local delivery of any high-dosage chemotherapy for treatment of organ cancer
• Company 143 - Vacuum-based clean surface nanotechnology for faster and larger osseointegration
• Company 144 - Technology for: 1-Glaucoma diagnosis and 2-Real-time homecare monitoring of intraocular pressure (IOP)
• Company 145 - Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft (CABG) surgery
• Company 146 - Therapeutic substances for bone regeneration
• Company 147 - Functionalized injectable biopolymers for medical applications
• Company 148 - Mobile air purification unit that captures and destroys airborne pathogens
• Company 149 - Therapy delivery platform for the upper airway with applications to initially target chronic sinusitis, nasal allergies, cystic fibrosis, and CPAP users
• Company 150 - 1-Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures, 2-Low profile single-patient-use tissue retractor, 3-Range of 7Fr intra aortic balloon catheters with fluid-filled technology that plugs into current hardware
• Company 151 - Percutaneous anastomosis device for vascular access
• Company 152 - Intelligent 3DHD visualization and guidance platform for ophthalmic, cranial, and spine surgeries
• Company 153 - Wireless/battery-less antenna on a chip (tag) for continuous tracking of blood samples
• Company 154 - Permanently implanted electrical neural stimulators to treat balance/hearing/perceptual disorders
• Company 155 - IV safety system with real-time, disposable ¥"smart¥" sensors
• Company 156 - Electrical stimulators via electrode garments for the treatment of pain related to chronic/acute soft tissue injuries
• Company 157 - Non-invasive neuromodulation platform technology
• Company 158 - Surgical instrument designed to solve recurrent problems in managing sutures, tissue reattachment, and visualization during surgical procedures
• Company 159 - Nanolayer surface technology to improve the osteoconductive/bio-resistant/anti-infective attributes of implants
• Company 160 - 1-Biopsy needles with enhanced ultrasound visualization, 2-Microencapsulated tissue markers, 3-Cryo-chemoablation of tumors
• Company 161 - Accommodative intra-ocular lens (IOL) technology to treat cataracts/presbyopia/impaired vision
• Company 162 - Systems to diagnose neurological and sleep disorders
• Company 163 - Technology that precisely eliminates irregularly shaped/invasive solid tumors while avoiding significant damage to surrounding healthy tissue and is non-toxic
• Company 164 - Extracellular matrix (ECM) implant that is completely integrated, remodeled, and replaced by the patient' s native tissue over time
• Company 165 - Non-surgical/injectable tissue revitalization and stabilization to address lower back pain (LBP) and the underlying problem of mechanical insufficiency
• Company 166 - 1-System for remote home patient monitoring of glucose, blood pressure, and thermal weight, 2-Glucose meter cell phone
• Company 167 - Non-invasive ophthalmic medical devices for: 1-diabetes screening and 2-daily glucose monitoring
• Company 168 - Implantable replacement valve to treat incompetent deep vein valves causing degenerative pain, swelling, and non-healing ulcers associated with chronic venous insufficiency (CVI)
• Company 169 - Highly porous resin that broadly removes toxins related to sepsis from blood
• Company 170 - Next-generation anatomic pathology (AP) with improved speed, automation, and ease-of-use
• Company 171 - Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI)
• Company 172 - Invisible/battery-less hearing device that is permanently implanted, yet completely reversible and MRI-compatible/safe
• Company 173 - Wireless device for the treatment of stress/urge/mixed urinary incontinence (UI)
• Company 174 - Communication device that acquires neurological signals from the brain and translates them into speech
• Company 175 - Visually guided catheter ablation for atrial fibrillation
• Company 176 - Next-generation vessel closure
• Company 177 - Pneumatic compression devices targeted to the lymphedema, venous insufficiency, and sports medicine markets
• Company 178 - Technology that enables the "packaging" of chronic therapies/biologics in an easy-to-use, disposable patch-like device
• Company 179 - Instrumentation that provides surgeons with real-time sensing/feedback from the operative site
• Company 180 - Lab-free salt intake monitor for hypertension/congestive heart failure (CHF) patients
• Company 181 - Endoscopically placed device for the treatment of obesity
• Company 182 - Minimally invasive radiofrequency (RF) device to treat aging skin
• Company 183 - Optical biopsy needle that will accurately diagnose prostate cancer, yet eliminate random prostate biopsies
• Company 184 - New holding company for various orthopaedic device companies, such as Enztec and OMNI life science
• Company 185 - Catheters for dissolving/removing cerebral blood clots then delivering therapeutics to the diseased site
• Company 186 - Targeted molecular assays for onco-diagnostics/personalized medicine
• Company 187 - Biomarker discovery platform for detecting Type 2 Diabetes, Prostate Cancer, and Amyotrophic Lateral Sclerosis (ALS, aka Lou Gehrig' s disease)
• Company 188 - Molecular diagnostic technologies for organ transplantation and various complex genetic disorders
• Company 189 - Non-invasive breast cancer diagnostic test via breast fluid analysis
• Company 190 - Non-invasive vascular disease detection that combines the advantages of MRI with the temporal resolution and ease-of-use of ultrasound
• Company 191 - Endoscopic/removable device that mimics the effects of gastric bypass surgery on a patient' s metabolism
• Company 192 - "Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly
• Company 193 - Imaging systems for the non-invasive, in vivo detection of cancerous and pre-cancerous lesions
• Company 194 - Microarray-based technology enabling targeted next-generation sequencing of genomic regions of interest
• Company 195 - Minimally invasive therapy for Emphysema
• Company 196 - Comfortable, soft, and pliable cloth mask for the treatment of obstructive sleep apnea
• Company 197 - Wearable neuroimaging cap for mapping brain function
• Company 198 - Computer-controlled rehabilitation table for the management of lower back pain
• Company 199 - 1-Bioactive/conductive polymer materials and coatings for implantable biomedical devices and 2-Next-generation all-polymer leads that may be grown in the body
• Company 200 - Non-invasive diagnostic prenatal testing via maternal blood test
• Company 201 - Devices to treat low back pain
• Company 202 - Wearable sensor technology that safely and accurately measures individual sleep patterns
• Company 203 - Peripherally inserted central catheter (PICC) that utilizes a sensor technology with handheld device for self-guided insertion
• Company 204 - Minimally invasive breast tumor diagnosis and treatment
• Company 205 - Lightweight, waterproof, medical alert pendant for seniors - to avoid the dangers of missed medications
• Company 206 - Non-invasive DNA-based prenatal diagnostic test
• Company 207 - Heart pump technologies
• Company 208 - DNA sequencing technology for the detection of biomarkers for infectious and other diseases
• Company 209 - Computer-assisted surgical devices for total joint replacement
• Company 210 - Diagnostic and therapeutic ophthalmic devices
• Company 211 - Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications
• Company 212 - Non-invasive neurostimulation device to restore vision to patients suffering from stroke, traumatic brain injury (TBI), dry age-related macular degeneration (AMD), and glaucoma
• Company 213 - Surgical/restorative dental implants
• Company 214 - Molecular diagnostic/prognostic tests for cancer
• Company 215 - Device to treat osteoarthritis
• Company 216 - Minimally invasive implant for treating spinal stenosis
• Company 217 - Non-polymeric drug-eluting stent (DES)
• Company 218 - Variety of diagnostic tests for infectious diseases, cardiology, hepatology, and various cancers
• Company 219 - Non-woven fabric with extended shelf-life to restore/repair tissue function
• Company 220 - Device for removing uterine fibroids without hysterectomy
• Company 221 - Wearable display technology to restore quality of life for those suffering from age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP)
• Company 222 - Diagnostic retinal imaging system for use in the primary care setting
• Company 223 - Easy-to-use/automated/rapid detection of severe infectious diseases
• Company 224 - Inferior vena cava (IVC) filter that includes: 1-automatic self-centering, 2-bi-directional deployment and retrieval, 3 -atraumatic design, and 4-total transluminal filtration
• Company 225 - Compliant balloon platform technology for use in neuroradiology, cardiovascular, and peripheral vascular applications
• Company 226 - Mechanical thrombectomy device to treat ischemic stroke
• Company 227 - Artificial heart technologies
• Company 228 - Cancer diagnostic test which enables the development of personalized therapeutics
• Company 229 - Bone graft material that is: 1- synthetic, 2-non-immunogenic, 3-inclusive of all bone regenerative properties of an autograft, and 4-cost-effective
• Company 230 - Portable/rapid cooling technologies via the nasal cavity to improve patient outcomes after cardiac arrest, stroke, or traumatic brain injury (TBI)
• Company 231 - Tests for the diagnosis/prognosis of cardiovascular disease
• Company 232 - Cost-effective solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract
• Company 233 - Neuromodulation for hypertension/heart failure
• Company 234 - System to repair abdominal aortic aneurysms (AAA)
• Company 235 - Endoscopic device to treat sinusitis
• Company 236 - Allogeneic cell therapy derived from the human placenta to mimic the natural environment of bone marrow
• Company 237 - Aortic embolic protection device for acute and long-term use
• Company 238 - Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury
• Company 239 - 1-Minimally invasive treatment of spinal compression, 2-Minimally invasive treatment of long bone factures, 3-Neuromodulation catheter that can be introduced into the spinal canal to treat pain
• Company 240 - Next-generation needleless drug delivery
• Company 241 - Minimally invasive neurosurgical and orthopedic instruments and implants
• Company 242 - Tissue fusion via infrared laser to replace sutures
• Company 243 - Ultrasound system that can measure true tissue elasticity in a reproducible/quantifiable/user-independent manner
• Company 244 - Next-generation nanostructured capacitors for: 1-implantable cardiac defibrillators (ICD) and 2-microsteerable cardiac ablation and related catheters
• Company 245 - Minimally invasive spine implant (facet versus pedicle screw)
• Company 246 - Spine implant that allows for post-operative adjustment of the implant size via radio control
• Company 247 - Spine fusion implant for motion preservation/dynamic stabilization
• Company 248 - Next-generation "permanent" biomaterial to reduce the risk of infection/thrombosis/restenosis
• Company 249 - Device for the treatment of benign prostate hypertrophy (BPH), prostatitis, erectile dysfunction (ED), lower urinary tract symptoms, and infertility
• Company 250 - Andara technology for the treatment of acute spinal cord injury
• Company 251 - Polymer implant to repair meniscal tears via tissue regeneration
• Company 252 - Electrodes/neural interface products for functional neurosurgery and neurostimulation
• Company 253 - Non-systemic/non-invasive system that delivers magnetic versus electrical pulses for the treatment of depression
• Company 254 - Implantable neuromodulation device designed to electrically alter the pain signal pathways
• Company 255 - Next-generation implants, stem cell enabling technology, and other minimally invasive surgical instruments
• Company 256 - Invisible hearing device
• Company 257 - Cooling and compression therapy for the relief of pain/swelling after orthopedic/other surgery
• Company 258 - Catheter insertion systems, designed for extended IV dwell time, to eliminate the risk of related bloodstream infections
• Company 259 - A monthly, rapid test to accurately monitor and potentially diagnose Diabetes
• Company 260 - Products for coronary bypass, valve repair and replacement, cardiac ablation, and heart failure surgery
• Company 261 - Biomaterial with exceptional hardness/low friction/bio-inertness that also prevents the leaching of metallic ions into the body
• Company 262 - Disposable and needleless patch that can be placed on the body inconspicuously for insulin delivery
• Company 263 - Small shunt-like device implanted into the bloodstream to modify, collect, or eliminate a broad range of Target Cells
• Company 264 - Artificial heart made of biosynthetic tissues, with two-pumps
• Company 265 - Permanently implantable/wireless/miniature sensors to transmit cardiac output, blood pressure, and heart rate data
• Company 266 - Fully implantable device for the treatment of central sleep apnea in heart failure patients
• Company 267 - Heart valve implant
• Company 268 - Tool for early diagnosis of age-related macular degeneration (AMD)
• Company 269 - Nanotechnology-based liquid that absorbs energy on a near-molecular scale versus relying on the mechanical properties of solid materials
• Company 270 - Cyanoacrylate-based products for wound care and infection prevention
• Company 271 - Femtosecond pulse laser system for various ophthalmic applications
• Company 272 - Technology that uses the patient' s own blood to make either: 1-A surgical sealant to prevent/stop bleedings or 2-A gel to stimulate the healing of chronic wounds
• Company 273 - Real-time/multi-user image communication/collaboration system that consolidates images and text records into a single point of access
• Company 274 - Polymer-based/biodegradable/drug-eluting peripheral vascular stent for tibial and infrapopliteal arteries
• Company 275 - Ultrasound-based diagnostic biosensor that enables blood analysis at the molecular level for the patient self-testing market
• Company 276 - Non-invasive biomechanical diagnostic system that records/analyzes range of motion (ROM) in a full 3-D environment for musculoskeletal diagnostics/therapeutics
• Company 277 - Minimally invasive/endoscopically-placed device to treat obesity by inducing satiety in the esophageal/cardiac portion of the stomach
• Company 278 - Continuous glucose monitoring specifically for use in the Intensive Care Unit (ICU)
• Company 279 - Real-time interactive training visualization system, specifically for the task of training any designated personnel in successfully accomplishing a limited "focused assessment with sonography for trauma" (FAST) examination
• Company 280 - Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and adenocarcinoma, 3-Identify more than 20 types of cancer
• Company 281 - Nasal stent to treat obstructive sleep apnea
• Company 282 - 1-Pacing/sensor-enabled device for Cardiac Resynchronization Therapy (CRT), 2-Real-time modality to quantify cardiac performance, 3-System that adds ingestible microchips to drugs
• Company 283 - Pocket-sized, affordable, and easy-to-use resuscitation devices that can be effectively deployed by both trained professionals and laymen
• Company 284 - Wearable health monitoring system for potential diabetes, heart disease, and sleep apnea applications
• Company 285 - Biomarkers for the screening and diagnosis of cervical and other cancers
• Company 286 - Wireless neurostimulation device to treat refractory chronic pain - 100 times smaller than current technology and injectable via a minimally invasive hypodermic needle
• Company 287 - Smart, accurate guiding device based on image technology for orthopedic trauma procedures such internal fixation with intramedullary (IM) nails, osteotomy, and others
• Company 288 - Non-invasive molecular diagnostics for autism, chronic obstructive pulmonary disease (COPD), multiple sclerosis, and diseases with a genetic susceptibility
• Company 289 - Natural polymer technology that mimics the physiological clotting cascade without reliance on blood-derived proteins - to stop severe bleeding, reinforce staple and suture lines, and repair tissues
• Company 290 - Effective and convenient phototherapy system available for in-home treatment of scalp/small-area psoriasis and other photo-responsive skin diseases
• Company 291 - Electroporation-delivered/DNA-based vaccines against cancers and infectious diseases
• Company 292 - Next-generation computer-assisted laparoscopic tool composed of multiple rigid elements with intervening controllable joints
• Company 293 - Low-cost/point-of-care (POC) analyzer to quantify hemostasis in whole blood, including cellular and plasma components
• Company 294 - Fluorescent markers/optical sensors that provide an accurate and rapid determination of kidney function
• Company 295 - Ocular scanner for rapid/non-invasive triage and detection of pre-symptomatic conditions including exposure to toxins, presence of systemic diseases, and indication of internal injury
• Company 296 - Endoscopically implantable devices for weight loss/to control Type 2 diabetes
• Company 297 - Catheter ablation for the treatment of cardiac arrhythmias
• Company 298 - Monitoring products/clinical services for advanced ambulatory cardiac monitoring
• Company 299 - Technology used in: 1-Finished products designed for micro-surgical/microscopy procedures and robotics and 2-Biosensors with applications in gene expression, neuroscience, and nanotechnology
• Company 300 - Resorbable hydrogel that 1-Seals annular tears in the intervertebral disc and 2-Provides an environment for nucleus regeneration
• Company 301 - Non-invasive/fast/easy-to-use/reliable medical devices that test for neuro-visual disorders
• Company 302 - High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis
• Company 303 - Technologies that integrate bone and cartilage forming peptide and small molecule therapies with osteostimulating matrices
• Company 304 - Non-invasive devices to identify patients with coronary artery disease (CAD) and other life-threatening cardiovascular conditions
• Company 305 - Injectable porous scaffolds/spheres/composites with fully interconnected pores, for multiple applications
• Company 306 - Compact, remote, wireless, real-time device for biomedical monitoring such as cardiac, neurological, sleep disorder, obstetrics, orthopedic, and other vital signs outside the hospital/clinic
• Company 307 - Permanent implant to address mitral regurgitation directly
• Company 308 - Portable/lab-quality diagnostics for the ER/ambulance/physician' s office/home/field
• Company 309 - Percutaneous injection treatment for patients with internal disc derangement (IDD) who have failed conservative care/are not yet candidates for total disc replacement (TDR)/spinal fusion
• Company 310 - Technology that allows surgeons to rapidly treat tissue at the surgical site/reduce blood loss
• Company 311 - A1c diabetes testing at the point of care, with results in under 4 minutes
• Company 312 - Next- generation/predictive blood tests to help warn of potential future health problems
• Company 313 - Vertebral compression fracture treatment
• Company 314 - Orthopedic imaging
• Company 315 - 1-Artificial vascular graft with self-sealing, non-woven, synthetic fiber structure, 2-Ventral hernia mesh
• Company 316 - 1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitinol peripheral stent, 3-Nano-based transcatheter, 4-Anatomy-specific combination embolic protection and stent delivery systems, 5-Localiz
• Company 317 - Early detection of Alzheimer' s disease via an eye drop and laser eye scan
• Company 318 - Drug-coated balloon angioplasty technology
• Company 319 - Behavioral remote patient monitoring system that uses wireless sensors to non-intrusively track and report on the daily patterns of seniors' activities
• Company 320 - System that assesses, then provides therapy to develop infant feeding skills
• Company 321 - Painless, continuous glucose monitoring
• Company 322 - Wireless/wearable/ultra-compact device that automatically tracks/wirelessly uploads data about a person' s activities (exercise intensity levels, calories burned, sleep quality, steps, distance)
• Company 323 - Joint reconstruction device that ideally/anatomically matches the size/shape of the facet joint
• Company 324 - Platforms for: 1- Pedicle screw fixation (even with poor bone quality), 2-Vertebral compression fractures, 3-Simple- to-use trauma products
• Company 325 - Implantable device for maintaining adequate blood flow to the brain in patients experiencing a buildup of excess cerebral spinal fluid (CSF) due to trauma
• Company 326 - 1- Straightforward knotless suture anchor, 2-Instrumentation for percutaneous suture management, 3- Endotendonous repair system, 4-Shape memory staples
• Company 327 - Coagulation analyzer to eliminate unnecessary blood transfusions
• Company 328 - Simple, rapid, blood-based cancer tests to provide accurate and individualized clinical information on disease status/treatment selection/treatment response
• Company 329 - Neurostimulator for cardiac contractility
• Company 330 - Endoscopically delivered devices focused on slowing gastric emptying, to treat all stages of obesity
• Company 331 - Autonomic nervous system stimulation for pulmonary and headache disorders
• Company 332 - Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy- to target and destroy cancerous/infected cells
• Company 333 - Technology for wound care and slow release drug delivery, by both transdermal and subcutaneous routes
• Company 334 - Intraoperative wavefront aberrometer for use in intraocular lens replacement surgeries
• Company 335 - Technology to treat atrial fibrillation that allows doctors to perform radiofrequency ablation under direct visualization
• Company 336 - Tests to "predict" chronic diseases/conditions, such as diabetes/osteoporotic bone fracture/a major cardiac event
• Company 337 - Disposable/miniature/minimally invasive surgical devices including reusable endoscopes for visualization, initially for use in spinal surgeries
• Company 338 - Dental implant that can be placed into a multi-rooted molar extraction site "immediately"
• Company 339 - Biocompatible and biodegradable synthetic scaffold to aid soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee
• Company 340 - Ingestible/wireless capsule with sensor technology to measure pH, pressure and temperature from within the entire GI tract
• Company 341 - Counter-stimulation technology to treat Restless Legs Syndrome (RLS)
• Company 342 - Minimally invasive device to treat emphysema
• Company 343 - Gene expression test for the diagnosis of ambiguous tumors
• Company 344 - Ocular metabolic imaging to "predict" eye diseases, including diabetic retinopathy/glaucoma/age-related macular degeneration
• Company 345 - Implantable neuromodulation device for the treatment of chronic pain and future applications
• Company 346 - Home-use devices for hair removal/acne/skin rejuvenation
• Company 347 - Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management
• Company 348 - Minimally invasive surgery system for simpler and safer soft-tissue suturing/fastening
• Company 349 - Effective/consistent/non-invasive neuromodulation for the treatment of urinary incontinence and future applications
• Company 350 - 1-Needleless mesotherapy to treat cellulite, 2-Non-invasive/non-thermal treatment for skin laxity/hypertrophic scars/striae
• Company 351 - Laparoscopic instruments that articulate/rotate/lock for single port access/"scar-less" surgery
• Company 352 - Miniature implantable sensors to accurately/continuously pinpoint the location of tumors in real-time, during radiation therapy delivery
• Company 353 - Manual rongeur and access tools for use in spinal decompression procedures
• Company 354 - Convenient/improved continuous glucose monitoring system
• Company 355 - Coating that triggers the body to generate nitric oxide (NO) at the device surface, by using naturally circulating blood substances
• Company 356 - Real-time/in vivo/cellular-level/3-D imaging for: image-guided surgery; early cancer diagnosis without a biopsy
• Company 357 - In vivo transdifferentiation to regenerate ischemic/diseased organs
• Company 358 - Real-time imaging for "dying" heart/brain/other tissue- non-invasive/non-radioactive/non-toxic
• Company 359 - True seizure "prediction"- up to an hour before the event
• Company 360 - Wearable mobile device to accurately measure real-time energy (calorie) expenditure/combat obesity
• Company 361 - 1-Non-embryonic cell technology that creates cells/tissues/organs for virtually anyone needing a transplant, 2-Non-toxic cancer vaccine that uses the body' s natural immune response to fight cancer, 3-Cell separation system to diagnose/monitor cancer
• Company 362 - Custom miniaturized mechanical components/devices for a broad range of medical device applications
• Company 363 - Wireless/disposable sleep-monitoring device
• Company 364 - 1-Next-generation, natural fibrin sealant, 2-Human thrombin
• Company 365 - Affordable, simple-to-use means of self-monitoring women' s reproductive status for: conception, birth control, ovulation, and cervical cancer screening
• Company 366 - Technologies that focus on wound diagnostics, infection control, and wound therapy
• Company 367 - Wireless/MEMS-fabricated/nano-processed/dermal/percutaneous continuous glucose monitoring device
• Company 368 - Diagnostic instrument to measure the material properties of bone
• Company 369 - Electronic brachytherapy that delivers non-isotope-based/localized/targeted radiation
• Company 370 - Minimally invasive method for lumbar spine decompression to treat patients with lumbar spinal stenosis (LSS), which may be performed in conventional operating rooms or interventional radiology suites with fluoroscopic imaging
• Company 371 - Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula
• Company 372 - Minimally invasive system to treat emphysema and resolve prolonged air leaks following lung surgery
• Company 373 - 3-D mesh pouches that are implanted empty, positioned, filled, then deployed to their full size for spinal/orthopedic applications
• Company 374 - Painless photo-pulsation technology for diminishing fine lines/wrinkles/age spots on the face/neck/hands
• Company 375 - Plastic surgery implantable devices for cosmetic and reconstructive surgery
• Company 376 - 1-Soft/disposable contact lens with embedded MEMS sensor for continuous intraocular pressure (IOP) monitoring in glaucoma patients, 2-Telemetry solutions for implantable medical devices
• Company 377 - Technology for the non-fusion treatment of scoliosis
• Company 378 - Atraumatic injectable plugs for 1-Temporary occlusion of blood vessels, 2-Kidney stone removal, and 3-future applications
• Company 379 - Percutaneously deliverable endograft to treat Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA)
• Company 380 - Optical Coherence Tomography (OCT) for sub-surface biological tissue imaging at much greater resolution than ultrasound/MRI/CT scanners
• Company 381 - Next-generation femtosecond laser that can operate inside the eye to make cataract surgery safer/more effective
• Company 382 - Totally implantable pumps delivering targeted medications directly to the spinal cord
• Company 383 - Rapid, point-of-care diagnostic tests for periodontitis/group A strep/systemic fungal infections, capable of detecting virulence markers produced ONLY during active infections
• Company 384 - Therapeutic gene delivery
• Company 385 - 1-Vertebral augmentation system and 2-On-demand ultra-high viscosity cement injection, for spinal applications
• Company 386 - Miniature implantable neurostimulator for treating central nervous system disorders
• Company 387 - Simple, point-of-care blood test for the detection/monitoring of traumatic brain injury (TBI)
• Company 388 - Resurfacing system to treat lesions/defects in the body' s weight bearing, non-weight bearing, and extremity joints
• Company 389 - Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring
• Company 390 - Technology to close incisions made during Natural Orifice Transluminal Endoscopic Surgery (NOTES) procedures
• Company 391 - Transitional in vivo imaging
• Company 392 - Collapsible titanium-alloy implant for spinal fusion
• Company 393 - Non-invasive type 2 diabetes and pre-diabetes screening with no blood draw/no fasting/no waiting for a lab result
• Company 394 - Devices for the destruction of pathogens responsible for: heart/blood/respiratory/gastrointestinal/periodontal/otological diseases, pancreatic cancer, and toe nail fungus
• Company 395 - Device that delivers a low-level/precisely controlled heat for the treatment of acne
• Company 396 - Nanomaterial-based MRI coil for higher image quality/faster scan times
• Company 397 - Handheld/at-home hair removal via laser
• Company 398 - Enhanced diabetes insulin pump
• Company 399 - Transpedicular/minimally invasive approach to vertebral body reconstruction/anterior spinal column support
• Company 400 - Next-generation Spinal Cord Stimulation (SCS) technology to treat chronic back/lower extremity pain
• Company 401 - Dynamic/intelligent ophthalmic lenses that automatically/electronically adjust focusing power
• Company 402 - Blood screening tests for breast and ovarian cancers
• Company 403 - Implantable/battery-less diagnostic system to allow orthopedic surgeons to monitor spinal fusion progress
• Company 404 - Next-generation coatings/advanced drug-delivery systems for cardiovascular stents and other implantable medical devices
• Company 405 - Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) device for patients being treated for heart attacks/in heart failure
• Company 406 - Ultra-thin/personalized/single-use/flexible/transdermal drug delivery patch
• Company 407 - DNA-based diagnostic tests for early identification/management of cancer/acute diseases
• Company 408 - Device with bio-active formulae to rapidly/painlessly treat/control the wound environment
• Company 409 - Less invasive treatment for chronic sinusitis delivered via non-nasal access
• Company 410 - Leadless/implantable pacing device for left ventricular stimulation/the treatment of heart failure
• Company 411 - Technologies to acquire/process/visualize data from 3-D breast imaging
• Company 412 - Mental stimulation system to help maintain mental acuity/quality of life
• Company 413 - Implantable device to treat high blood pressure that cannot be controlled with medications/lifestyle modifications
• Company 414 - Polymer technologies for cardiac/cranio-maxillofacial/orthopedic surgery applications
• Company 415 - Leadless/subcutaneously implantable cardiac defibrillator (ICD)
• Company 416 - 1-Handheld intelligent bone sculpting tool, 2-X-ray vision that appears "within" the patient
• Company 417 - Synthetic peptides for tissue regeneration for the treatment of musculoskeletal/vascular/chronic wound diseases
• Company 418 - Radiofrequency (RF) energy to reshape the cornea without incision
• Company 419 - Endovascular treatment of peripheral arterial blood vessels that require re-vascularization
• Company 420 - Cells derived from bone marrow which can be used in an allogeneic/off-the-shelf setting to treat kidney/other difficult to treat diseases
• Company 421 - Thin-walled/removable/entirely covered stents designed to match the site to be treated and the surrounding anatomy
• Company 422 - Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery
• Company 423 - Single device for high-frequency ultrasound imaging/therapeutic treatment
• Company 424 - Low-level laser technology for aesthetics, bone healing, neck/shoulder pain, and wound healing
• Company 425 - Light-based aesthetic systems that are pain-free/seven times faster than existing systems
• Company 426 - 1-Image analysis technology for virus detection/analysis, 2-Antiviral drugs
• Company 427 - Simultaneous testing of sobriety and identy that is simple/rapid/non-invasive, requiring no bodily fluids
• Company 428 - Technology for diagnosing breast and ovarian cancers and determining responsiveness to new therapeutics
• Company 429 - Synthetic graft/stent technology that reduces neo-intimal hyperplasia (NIH) and occurrence/rate of restenosis
• Company 430 - Disposable endoscopic assist device that can be used with existing equipment to significantly improve flexible endoscopy procedures
• Company 431 - Systems using radiofrequency (RF) energy for the treatment of GERD and fecal incontinence (FI)
• Company 432 - Sutureless anastomosis systems to reduce/eliminate cross clamping time and suturing during minimally invasive surgery (MIS)
• Company 433 - Anti-infective compounds designed to mimic host defense proteins, but with completely synthetic/non-peptide backbones
• Company 434 - Minimally invasive interstitial laser therapy (ILT) as an alternative to breast surgery
• Company 435 - Less invasive approach for mitral valve repair, on a beating heart
• Company 436 - High-resolution dermoscopy imaging technology to identify melanoma at an earlier stage/reduce the number of unnecessary excisions
• Company 437 - Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and thrombus
• Company 438 - Heart rate variability (HRV) analysis for quantitative assessment of the autonomic nervous system (ANS)
• Company 439 - Wireless/motorized orthopedic lengthening implants for applications in deformity correction/cosmetic limb lengthening/bone fractures
• Company 440 - 3-D scaffold that enhances the biointegration of percutaneous/fully implanted current and next-generation devices
• Company 441 - Injectable gels for localized and controlled release of biologicals
• Company 442 - Portable/palm-held endoscopic imaging with a mobile platform for recording/sharing/archiving images
• Company 443 - Hand-held ultrasound device to quantify strain and stiffness of tendons/ligaments
• Company 444 - Lightweight brace support suit that restores mobility function for paraplegics/lower limb paralysis patients
• Company 445 - Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases
• Company 446 - Cobalt-chromium, balloon-expandable stent, which marries with approved DES to treat the entire spectrum of coronary artery bifurcation lesions
• Company 447 - Non-invasive intracranial pressure monitor to diagnose/treat head injury
• Company 448 - Temperature-controlled/multi-functional next-generation cutting/sealing product
• Company 449 - Interspinous/interlaminar functionally dynamic stabilization device and other non-fusion scoliosis technologies
• Company 450 - CO2 lasers through flexible/rigid endoscopes for use in minimally invasive surgery and soft tissue procedures in otolaryngology/head and neck surgery/pulmonology
• Company 451 - Real-time/PCR-based molecular diagnostic tests for life-threatening respiratory fungal infections
• Company 452 - Ultra-lightweight/soft/non-palpable mesh technology to treat urinary stress incontinence/pelvic organ prolapse
• Company 453 - Digital pump with no mechanical parts for drug delivery/infusion therapies
• Company 454 - Surgical implants and biological products for spinal surgery
• Company 455 - In situ formed hydrogels designed/indicated for ophthalmic surgery
• Company 456 - Light-activated glue system to stabilize shattered bone
• Company 457 - Non-contact imaging system that provides local anatomical and oxygenation information
• Company 458 - Affordable/good quality standard-of-care surgical devices
• Company 459 - Low-dose-rate brachytherapy that will replace individual seeds and provide more uniform/consistent radiation delivery to patients
• Company 460 - Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF)
• Company 461 - Aortic valve bypass graft system for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy
• Company 462 - Single-use catheter device w/controller that delivers radiofrequency energy during outpatient bronchial thermoplasty for the treatment of asthma
• Company 463 - Ultrasonic energy for the selective dissection/fragmentation/debridement/cleansing of tissues
• Company 464 - Percutaneous soft tissue lifts for the breast/neck/other soft tissue structures
• Company 465 - Bioresorbable polymer surgical implants designed to prevent/reduce the formation of post-operative adhesions
• Company 466 - Implanted electronic subretinal device to restore vision to those who are blind due to retinitis pigmentosa (RP) or age-related macular degeneration (AMD)
• Company 467 - Noninvasive tests for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorectal cancer
• Company 468 - Guidewire system intended to safely/quickly cross occluded peripheral and coronary vessels
• Company 469 - Matrix therapy based technology that treats skin ulcers/reduces amputation
• Company 470 - Artificial muscle technology for the treatment of faecal and urinary incontinence
• Company 471 - Technology that selectively treats only cancer cells and avoids destruction of normal cells
• Company 472 - Full line of precision-crafted/disposable/ultra-minimally invasive surgical instruments
• Company 473 - Beam steering/target tracking/treatment planning solutions to the external beam radiation therapy market
• Company 474 - Device that uses combined electric field and low-intensity, noninvasive ultrasound for the treatment of solid tumors without the need for chemotherapy
• Company 475 - One-shot, instantaneous anastomotic stapling devices for open AAA, EVAR, and CLI applications
• Company 476 - Stent to treat cerebral/aortic aneurysms by modulating hemodynamic flow
• Company 477 - Biomotion sensors that enable easy/non-contact capture of high-quality physiological data- remotely/wirelessly
• Company 478 - Flexible/single-use/sterile video-endoscopes which may be used at the patient bedside and which avoid all cross-contamination risks
• Company 479 - Therapeutic gene delivery to treat diabetes/obesity/intestinal disorders/hemophilia/anemia
• Company 480 - Non-invasive technique for sampling the surface layers of the skin to generate individual genetic profiles for diagnostic/prognostics
• Company 481 - Non-invasive method designed to only kill fat cells and not harm the skin or other tissue
• Company 482 - 3-D/single-piece/dual optic accommodating intraocular lens (IOL)
• Company 483 - Cellular therapy to act directly at the level of the cause of autoimmune disorders, the dysregulated immune regulation
• Company 484 - Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA
• Company 485 - Real-time endoscopic tissue imaging system for high-resolution visualization of bronchial/pulmonary tissue cross-sections without biopsy
• Company 486 - Very strong/customizable/biomimetic/easily revisable artificial disc implant, requiring no assembly in situ
• Company 487 - Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque
• Company 488 - Advanced method of photocoagulation to provide more rapid, precise, and safe treatment for a variety of retinal conditions
• Company 489 - Next-generation personal diagnostics for hematological malignancies/autoimmune disorders
• Company 490 - Soft tissue repair/replacement, using proprietary chemistry and organic collagen matrices
• Company 491 - Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema
• Company 492 - Phototherapy/ultraviolet light to inactivate the organisms that cause nail infections
• Company 493 - Technology enabling detection and monitoring wirelessly, remotely, and with no contact to the subjects; also through clothing/barriers
• Company 494 - Biochips to identify gene expression patterns
• Company 495 - Automated blood analysis at point-of-care
• Company 496 - Applicator for breast brachytherapy that delivers targeted dose of radiation
• Company 497 - MRI contrast agents to monitor the position/quantity of transplanted cells non-invasively in vivo
• Company 498 - A soft tissue aperture fixation system for anterior cruciate ligament (ACL) reconstruction using the hamstring/other soft tissue grafts
• Company 499 - Non-invasive/convenient measurement and monitoring of human hydration status, using saliva as a sample
• Company 500 - Cryotherapy to ablate diseased tissue
• Company 501 - Reliable/accurate/solid-state laser system for customized treatment of many vision disorders
• Company 502 - Non-invasive/iontophoretic drug delivery system with broad applicability for treating serious ocular diseases
• Company 503 - Electrical stimulation technology along with single-use disposables to restore continence control to individuals with abdominal ostomies/eliminate the need for traditional ostomy pouching systems
• Company 504 - MRI-guided laser ablation system for targeted, minimally invasive, focal tumor therapy
• Company 505 - Medical devices that enable earlier detection/minimally invasive treatment of lung cancer
• Company 506 - Non-invasive devices for the treatment of superficial venous disease
• Company 507 - Truly minimally invasive or open system utilizing a proprietary uni-axial screw at one-half the cost of poly-axial systems for all spine disorders
• Company 508 - Catheter-based systems that will provide very rapid/selective hypothermia to various body organs and locations
• Company 509 - Cardiac assist device for patients in moderate/severe long-term heart failure
• Company 510 - Digital image acquisition, coupled with proprietary CAD decision-making algorithms, to provide an immediate/automated colposcopic evaluation
• Company 511 - Robotic system for fabrication of nano-material based wound dressings, delivered on-demand, at the POC
• Company 512 - Unique spine functional testing that delivers improved surgical outcomes
• Company 513 - Electromagnetic thermal therapy to relieve pain/improve function in patients suffering from osteoarthritis
• Company 514 - System to inactivate pathogens in all three major blood components: platelets/plasma/red cells
• Company 515 - Therapeutic approaches to prevent the abnormal tissue growth that inhibits recovery from surgical procedures/impairs normal wound healing
• Company 516 - Biocompatible shape memory polymers which can be programmed to change shapes/rigidity when an initiating stimulus is applied
• Company 517 - Disposable laboratory-on-a-card ("lab card") device to deliver sample-to-result analyses in minutes at the point of patient-caregiver contact
• Company 518 - Technologies that will prevent infection for many large patient populations
• Company 519 - Light-activated drug therapy to transform cancer into a treatable chronic disease
• Company 520 - 1-Percutaneous venous valve, 2-Inferior vena cava filter, 3-Multi-purpose/disposable laparoscopic scissor grasper, 4-Multi-sized/multi-stiffness guidewire
• Company 521 - Non-invasive infrared imaging system for the early detection of breast cancer
• Company 522 - Device for the treatment of sudden cardiac arrest for both in- and out-of-hospital markets
• Company 523 - Line of antimicrobial coatings to prevent microbial colonization/biofilm formation of endotracheal tubes/other indwelling medical devices
• Company 524 - 3-D tracking devices for use in surgical navigation and MIS
• Company 525 - Implantable patient alerting system for the detection and prevention of heart attacks
• Company 526 - Minimally invasive/RF nerve ablation to reduce of migraine headache pain
• Company 527 - Less invasive devices for the treatment of glaucoma, intended to replace current therapies
• Company 528 - Natural cell-based technologies to restore normal neuron function in the central nervous system
• Company 529 - Non-invasive/urine-based diagnostic assays for specific cancer types
• Company 530 - Fluid-controlled accommodating intraocular lens (IOL) to restore vision of youth to middle-aged/elderly individuals
• Company 531 - Single, multi-cannula laparoscopic port and specially designed curved instrumentation
• Company 532 - Technology that provides the precision of a scalpel and the bleeding control of traditional electrosurgery, without extensive collateral tissue damage
• Company 533 - More viable/cost-effective method for treating intracranial aneurysms
• Company 534 - System that enables consistent tissue contact/complete lesions during cardiac surgery for the treatment of arrhythmias
• Company 535 - Non-invasive neurorehabilitation system
• Company 536 - Cerebral protection system to prevent embolic strokes
• Company 537 - Catheter-based drug delivery using high-frequency/low-power ultrasound
• Company 538 - Technology for real-time identification/localization of cancer cell clusters to enable complete/residual-free therapeutic excisions
• Company 539 - Third-generation cancer-associated biomarkers using proteomics
• Company 540 - Non-invasive electrocardiographic imaging
• Company 541 - Modified bioactive ceramics and second-generation tissue regeneration smart materials
• Company 542 - Minimally invasive/flexible spinal implant technology to treat vertebral compression fractures and degenerative disc disease
• Company 543 - Catheter-based drug delivery system designed to dissolve blood clots in a single/rapid/one-step procedure
• Company 544 - Rapid DNA-based point-of-care diagnostics
• Company 545 - Joint prostheses as an adjunct to laminectomy/laminotomy/neural decompression/facetectomy, in lieu of fusion
• Company 546 - Advanced trilobal pericardial valve technologies
• Company 547 - Protective coatings for medical instrumentation to combat bacterial biofilms
• Company 548 - Wireless ECG monitoring
• Company 549 - De-cellularized biological scaffolds meant to function like native tissue
• Company 550 - Non-invasive, wearable, watch-sized metabolism measurement system that employs the use of a low-cost proprietary disposable sensor using direct-calorimetry, to accurately measure minute-by-minute caloric expenditures
• Company 551 - Advanced, intuitive real-time imaging for abdominal minimally invasive surgery
• Company 552 - Direct/real-time/non-invasive vascular imaging via infrared light to visualize both superficial veins/more deeply-located arteries
• Company 553 - Extracellular matrix derived from fibroblasts isolated from newborns (NO embryonic stem cells/animal products)
• Company 554 - Next-generation cell-based/tissue-engineered products
• Company 555 - Mesh wrap for permanent implantation around the heart to prevent/reverse the progression of heart failure
• Company 556 - Handheld/breath-based blood glucose monitor
• Company 557 - More targeted/accurate radiation of cancer cells with significantly fewer side-effects
• Company 558 - Bioactive glass-ceramic material that offers whiter and less-sensitive teeth while protecting from tooth decay
• Company 559 - Membrane optimization, coatings technologies, and development of polymers for biomedical applications
• Company 560 - System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point-of-care and in just 15 minutes
• Company 561 - Devices to control bleeding post-hysterectomy/in other cases of pelvic area trauma
• Company 562 - Painless system that improves the appearance of cellulite/relieves minor muscle aches, pain, and spasms/temporarily improves local blood circulation
• Company 563 - Non-invasive/fast/accurate diagnostic kits for: fertility, hormones, infectious agents, auto-antibodies, and tumor markers
• Company 564 - Gene therapy products for the treatment of inherited/acquired diseases.
• Company 565 - Stent technology for the treatment of atherosclerotic disease at/near bifurcations
• Company 566 - Neo-organs/tissues derived from the patient' s own (autologous) cells
• Company 567 - Computer-controlled pressure garments for the effective treatment of lymphedema/chronic wound healing
• Company 568 - Small/portable/disposable infusion pump kit to treat post-operative pain more effectively than narcotics
• Company 569 - Pulsatile perfusion generator technology to greatly enhance the preservation time window and organ transplant quality
• Company 570 - Second-generation electronic retinal implant to treat blindness due to retinitis pigmentosa
• Company 571 - Device to improve drainage following heart, lung, and trauma surgery, as well as other procedures where drainage is critical
• Company 572 - Next-generation/fully-automated/electronically-controlled/self-contained blood glucose system
• Company 573 - Minimally invasive system for treating long-bone fractures using an intermedullary stent/cement
• Company 574 - Non-invasive measurement of magnetic fields to diagnose functional brain disorders
• Company 575 - Products to diagnose/treat dry and wet age-related macular degeneration (AMD) and other chronic diseases involving the alternative complement system
• Company 576 - Wearable artificial kidney device
• Company 577 - Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
• Company 578 - Miniature patch that dispenses insulin
• Company 579 - Microcatheter and imaging technologies for interventional ophthalmology
• Company 580 - Transcutaneous yet needleless drug delivery system for the injection of drugs/vaccines in solid doses
• Company 581 - Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs on an as-needed basis
• Company 582 - Device to percutaneously repair the mitral valve
• Company 583 - Miniature intravascular flow augmentation device for every organ that needs temporary change of flow
• Company 584 - Minimally invasive surgical procedure intended to reduce the incidence of stroke/thromboembolism associated with atrial fibrillation
• Company 585 - Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claudication
• Company 586 - A platform for minimally-invasive cardiac surgery (MICS) via single-port, subxiphoid access, and an endoscope that reaches any anatomical location, including complex paths, from one single access port
• Company 587 - Percutaneous mitral valve replacement (PMVR) for Mitral Regurgitation (MR)
• Company 588 - Medical devices for the osteoarthritis/rhinosinusitis markets
• Company 589 - Miniaturized ultrasound probe that is easier-to-use/more flexible
• Company 590 - Resonating sensor made out of piezoelectric ceramics that can be miniaturized and is suitable for use in diagnostic equipment
• Company 591 - Bioresorbable peripheral/coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty
• Company 592 - Disposable devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
• Company 593 - True 3-D imaging to improve evaluation/planning of radiation treatments
• Company 594 - Next-generation spinal implants
• Company 595 - New unilateral posterior fusion technology
• Company 596 - Products for nuclear replacement/augmentation, vertebral compression fracture repair, and spinal fusion
• Company 597 - Second-generation, metal-on-metal cervical/lumbar artificial discs
• Company 598 - Artificial cervical disc with controlled range of motion in all six degrees of freedom
• Company 599 - Next-generation of biomaterials for spinal implants
• Company 600 - Intradiscal arthroplasty device utilizing articulating PEEK-on-PEEK material
• Company 601 - Hydrogel matrix with applications across multiple specialties
• Company 602 - Intelligent microgels as injectable scaffolds for intervertebral disc repair
• Company 603 - Minimally invasive disc augmentation system to repair/rehabilitate an intervertebral disc
• Company 604 - Implant designed to retain motion following the removal of diseased disc and/or bone material in the upper spine
• Company 605 - Tissue repair/surgical mesh systems for soft tissue repair
• Company 606 - Silicon nitride implants with 3-D structured cancellous ceramic for strong capillary action
• Company 607 - Tibial knee implant for stable fixation to the medial tibial plateau without bone cuts/cement/screws
• Company 608 - Technologies to treat obstructive sleep apnea and snoring
• Company 609 - Anatomically-driven/minimally invasive spinal products for motion preservation
• Company 610 - Tissue engineering technologies for orthopedic/sports medicine patients
• Company 611 - Real-time imaging/image guidance for the operating room
• Company 612 - Stent that provides protection from embolic showers during/post-procedure
• Company 613 - Minimally invasive vapor technology to treat emphysema
• Company 614 - Human-based tissue scaffolds
• Company 615 - Simple, low-cost infusion pump that contains the IV bag within it
• Company 616 - Non-intrusive patient-monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration
• Company 617 - Bifurcated stenting
• Company 618 - Bioabsorbable implants for accurate soft tissue fixation either to apposing soft tissue/to bone
• Company 619 - Drug delivery vehicles that can easily be targeted to specific cell types/disease state tissues
• Company 620 - Minimally invasive therapies for interventional neuroradiology
• Company 621 - Treatment for ischemia via stem cell-based therapies
• Company 622 - Cellular therapy device to treat liver disease
• Company 623 - Customizable vibration therapy devices to stimulate bone/muscle tissue
• Company 624 - Deep brain stimulation (DBS) guidance system
• Company 625 - Cellular imaging technology, using the Internet to transfer real-time/secure/accurate cellular resolution images
• Company 626 - Minimally-invasive percutaneous aortic valve replacement systems
• Company 627 - Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration
• Company 628 - Advanced detection, staging, endoscopic treatment and follow-up care for acute and chronic lung disease
• Company 629 - Minimally invasive therapy for the treatment of chronic disc pain
• Company 630 - A minimally invasive device for stomach-reduction surgery consisting of a stapling tool that can be passed down the throat into the stomach
• Company 631 - Kidney stone management device and urethral dilating introducer
• Company 632 - Ventricular elastic support therapy for heart failure
• Company 633 - Plastic medical devices for gynecological exams and surgeries
• Company 634 - Inferior vena cava filters
• Company 635 - Neuromodulation system for both traumatic brain injury (TBI) and stroke
• Company 636 - Minimally traumatic, bone- and cartilage-preserving knee implants and instrumentation
• Company 637 - Electrosurgical instruments
• Company 638 - Fast, accurate, and easy-to-use in vitro molecular diagnostic products that rapidly identify infectious pathogens
• Company 639 - Unique spinal implant designed to promote rapid fusion
• Company 640 - Devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
• Company 641 - Unique transcranial magnetic stimulation system that allows direct non-invasive activation of deep brain structures
• Company 642 - Dynamic "shape memory" platform to optimize mitral/tricuspid valve repair
• Company 643 - Single molecule DNA analysis system, with no requirement for prior sequence information/PCR/cloning/probes
• Company 644 - Biomaterials-based medical devices focusing on cardiovascular, metabolic, inflammatory, and fibrotic diseases
• Company 645 - Transdermal/wound dressing/mucosal drug delivery
• Company 646 - A unique solution similar to ring annuloplasty/edge-to-edge repair, all in one modality, for mitral valve repair
• Company 647 - Minimally invasive devices that improve oxygenation for patients with COPD
• Company 648 - Hands-free internal retractor/internally-anchored laparoscope camera cleaner
• Company 649 - Particle technologies for the treatment/prevention of chronic respiratory disorders
• Company 650 - Minimally invasive, single-procedure approach for the repair of cartilage damage/osteoarthritis
• Company 651 - Biodegradable synthetic hydrogels for general and specialty surgery use
• Company 652 - Silk-based biomaterial platforms for tissue rejuvenation/connective tissue repair
• Company 653 - Ankle replacement implant for patients with chronic pain/arthritis
• Company 654 - Biomarker assays for the early detection of cancer
• Company 655 - 1-Painless intradermal drug delivery, 2-GERD diagnostic device, 3-Non-invasive continuous glucose monitoring
• Company 656 - Detection products for viral/bacterial infections, genetic diseases, mutations, cancers, etc.
• Company 657 - Video integration and equipment management system to enhance the MIS market
• Company 658 - Multi-pixel x-ray source for enhanced system performance/new capabilities
• Company 659 - Combination ultrasound/electrical stimulation device for skin rejuvenation
• Company 660 - Bioprosthetic heart valve with a percutaneously-exchangeable leaflet set that provides lifetime service without anti-coagulation therapy
• Company 661 - Advanced suturing technology for minimally invasive/NOTES/bariatric/cardiac/other surgical specialties
• Company 662 - A minimally invasive electromagnetic navigation system for early detection of lung cancer
• Company 663 - Patient-centric data system and analysis tools for translational medicine and research
• Company 664 - Hand-held device to monitor post-operative/trauma patients for early warning signs of sepsis or infection in the bloodstream
• Company 665 - Spinal cage with dynamic stabilization/MIS placement (3mm access) and easily revisable
• Company 666 - Fully modular total hip replacement systems to reduce wear/add longevity
• Company 667 - A "plug & play" system for treating non-invasive, curative, and palliative cancers and precursors
• Company 668 - Products for the early detection of lung and oral cancers
• Company 669 - System that performs a non-invasive, 30-second test to identify the risk of heart disease
• Company 670 - Non-molecular bacterial screening, identification, and antibiotic susceptibility testing
• Company 671 - Optical coherence tomography for evaluation of human tissue microstructure with real-time depth visualization
• Company 672 - Wireless electronic skin patch sensors for the real-time measurement/monitoring/diagnosis/clinical management of cardiac arrhythmias
• Company 673 - Non-fusion spinal solutions that control segmental motion/maintain the neutral zone simultaneously
• Company 674 - Optical cell sorters used in stem cell/cell therapy treatments for cancer, autoimmune disease, and regenerative medicine applications
• Company 675 - BQTR, a non-invasive point-of-care diagnostic test for osteoporosis and bone fracture risk
• Company 676 - Low-mass PFO closure system capable of repairing the defect from within the tunnel
• Company 677 - Third-generation biodegradable annuloplasty rings
• Company 678 - Easy-to-use, instrument-free, disposable molecular diagnostic tests
• Company 679 - 1-Bone cement to replace PMMA-based materials, 2-A liquid hydrogel wound dressing able to cure rapidly and in situ
• Company 680 - Monitoring system to replace the manual assessment of labor progress with real-time/continuous information
• Company 681 - Delivery of proteins and peptide drugs without burst, with near-zero order release, and with high bioavailability
• Company 682 - Contrast agents/molecular imaging for detection using a modified porous Silicon (mpSi"!) platform
• Company 683 - New generation of high-power/compact lasers for cosmetic, dermatology, pain management, and wound applications
• Company 684 - SutureCross"!: Knotless Anatomic Fixation System for double row arthroscopic rotator cuff repair
• Company 685 - Biodegradable surgical adhesive for seroma reduction in plastic surgery
• Company 686 - Miniature blood pump, designed to be placed superficially like a pacemaker, for the long-term treatment of chronic heart failure (CHF)
• Company 687 - Devices that use bio-electric stimulation therapy (bio-current) to treat hard-to-heal wounds
• Company 688 - Minimally invasive catheter-based ablation technologies to treat atrial fibrillation and other cardiac arrhythmias
• Company 689 - Transvaginal, ultrasound image-guided HIFU device, capable of real-time guidance and monitoring of therapy
• Company 690 - A portable breath collection apparatus (BCA) which can collect breath samples virtually anywhere, for highly sensitive laboratory analysis
• Company 691 - Automatic tools to support image visualization, lesion detection and quantification, temporal evolution assessment, and automatic reporting in chest and abdominal CT scans
• Company 692 - RNA-based therapeutics
• Company 693 - Wireless seizure alarm systems for people with epilepsy
• Company 694 - Arm training device to restore arm movement in stroke patients who have experienced arm paralysis
• Company 695 - Ophthalmic formulation of mitomycin-C in a single-use kit, for use in the surgical treatment of glaucoma
• Company 696 - Products to diagnose the risk for heart attacks by means of assessing endothelial function
• Company 697 - Minimally invasive medical devices for patients who are at risk for or have suffered a stroke
• Company 698 - AOKit"!-bio: an adaptive optics kit for biologists which enhances microscopic imaging
• Company 699 - NeowaterR, a water-based nanotechnology which has physical properties that mimic intracellular water
• Company 700 - Metabolomic profiling of biomarkers for the diagnosis of early forms of dementia and neurodegenerative diseases
• Company 701 - A portable oxygen delivery and ventilation system
• Company 702 - Interventional bronchoscopy devices for lung diseases
• Company 703 - Advanced endotracheal tube for intubation, fitted with advanced fiberoptic visualization technology
• Company 704 - Modular hip stem technology and total knee replacement systems
• Company 705 - First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure ("CHF")
• Company 706 - Fusion and non-fusion spinal implants
• Company 707 - A device that seals blood vessels after hemodialysis as an alternative to central venous catheters for kidney-dialysis patients
• Company 708 - Non-invasive ultrasound body contouring
• Company 709 - Non-invasive, painless, Navigated Brain Stimulation (NBS) for brain diagnostics and therapy
• Company 710 - Noninvasive breast cancer risk assessment device
• Company 711 - Low cost, easy-to-use, credit-card-sized devices which will allow on-the-spot quantitative diagnosis
• Company 712 - Telemedicine paired with state-of-the-art ophthalmologic imaging
• Company 713 - Devices for treating cardiovascular disease
• Company 714 - Precision surgical systems for computer-assisted 3D planning, surgical navigation, and surgeon-controlled robotic surgery
• Company 715 - Female sterilization technology
• Company 716 - Electromedical/electrotherapeutic equipment
• Company 717 - Products for the minimally invasive repair of long bone fractures
• Company 718 - Molecular diagnostic products for laboratories that are intended to enhance medical care by providing early diagnostic information rapidly
• Company 719 - New pulmonary drug delivery system
• Company 720 - Next-generation laser therapy
• Company 721 - Devices for the in-office polypectomy/myomectomy market
• Company 722 - Low-cost, fast, and accurate molecular diagnostic products
• Company 723 - EXPANSE Vertebral Body Replacement Device for use in the thoracolumbar spine
• Company 724 - A software based thermal mapping system that will be used in conjunction with CT and planar x-ray imaging systems
• Company 725 - Minimally invasive, single-use, disposable devices that enable incisionless, transoral procedures for the treatment of a number of upper gastrointestinal problems, including gastrointestinal reflux disease (GERD) and failed bariatric surgery
• Company 726 - Mobile phone-based data collection for chronic disease management
• Company 727 - Advanced gene expression and DNA quantification products and services
• Company 728 - Optical backscatter technology to improve the way cancer is detected and diagnosed
• Company 729 - Laser, light-based, and radiofrequency devices for aesthetic and medical applications
• Company 730 - Diagnostic methods using microarray gene expression profiling to determine specific properties of tumors
• Company 731 - Catheter-based devices which rapidly provide quantitative data to the physician about vessel and stent size, suitable for peripheral and cardiac applications
• Company 732 - Advanced wheelchair technologies
• Company 733 - Human bionic devices that can instantaneously interact with the human body to replace or restore biomechanical or physiological functions
• Company 734 - Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue
• Company 735 - Methods for treating human tissue based on volumetric bipolar radio frequency ablation (RFA), and surface ablation of tissue
• Company 736 - Infusing normothermic fluids from 10mL/hour-1200mL/minute with 30-second setup through a disposable cassette
• Company 737 - Technology using opto-acoustics for functional imaging/cancer diagnosis
• Company 738 - High-intensity focused ultrasound in a catheter to treat atrial fibrillation
• Company 739 - 1-Alternative to instrument-based viscosity testing; 2-A disposable blood to plasma device for use in micro-fluidic assays; 3-A home-use test for clotting time
• Company 740 - Portable, easy-to-use consumer device that allows for easy, safe and green disposal of used insulin syringes, lancets and pen needles by vaporizing the sharp
• Company 741 - Site-specific catheter-guided system to deliver drugs and biologics directly to the adventitia
• Company 742 - Device based therapy targeting ischemic brain stroke and chronic heart failure
• Company 743 - Integrated wireless monitoring
• Company 744 - Non-invasive robotic radiosurgery system for cardiac ablation
• Company 745 - Ceramic components for spine, orthopaedic, and other implant needs
• Company 746 - Target-specific recombinant human protein focused on spinal fusion surgery
• Company 747 - Patient controlled analgesia device for pain management
• Company 748 - Less invasive orthopaedic implant solutions employing advanced pliable structured materials and innovative designs
• Company 749 - Dual function, automatic, handheld sinus irrigator and aspirator for OTC consumer use
• Company 750 - Computer-integrated robotic instrumentation/navigation tools for orthopedic surgery
• Company 751 - Next-generation disposable colonoscope incorporating diagnostic/therapeutic capabilities allowing for a potentially sedation-less treatment
• Company 752 - Total hip replacement system that addresses resistance to wear and resistance to dislocation with ceramic and double mobility
• Company 753 - Percutaneous mitral valve replacement system for treatment of mitral regurgitation
• Company 754 - Non-invasive continuous glucose monitoring device, for patients with diabetes, based on a multi-sensor platform
• Company 755 - Growth factor and biomaterial addressing the needs of spinal fusion, osteochondral defects, osteoarthritis, dental medicine, and other indications
• Company 756 - Open-architecture, cryogenic-free MRI systems for orthopaedic, general purpose and interventional applications
• Company 757 - Minimally invasive retractors for pelvic surgery to optimize pneumoperitoneum pressure and patient position (OP5)
• Company 758 - Handheld device which measures the amount of calories a person requires to maintain body weight
• Company 759 - Intelligent nasal drug delivery devices for topical, systemic and nose-to-brain applications
• Company 760 - Developing a fully implantable extra-aortic counterpulsation device designed to provide long-term, cost-effective treatment and significantly improve quality of life for heart failure patients
• Company 761 - An absolutely non-invasive, radiation- and side-effect free electro physiological high speed cardiac diagnostic system to identify upcoming heart attacks and sudden cardiac deaths
• Company 762 - DART is utilizing an interstitial radiation source that by nuclear decay recoil mechanism emits high-energy alpha particles widely dispersed by diffusion and by convection in the tumor mass
• Company 763 - Producer of surgical devices including a self-attaching hernia patch, anti-clog surgical drain, and cavity implosion device
• Company 764 - Non-surgical serum based cure, proven effective for PAD, Diabetic and Cardiovascular disorders
• Company 765 - Portable and networked medical devices such as handheld ultrasounds
• Company 766 - Single-use rigid endoscopes, with superior image quality, at a reduced per-use cost
• Company 767 - Providing private and hospital-based OB/GYNs, Perinatologists, and Radiologists with integrated reporting and image management systems
• Company 768 - Minimally invasive ophthalmic device therapy for Dry Macular Degeneration and other blindness causing diseases
• Company 769 - Minimally invasive surgical technology that uses ionizing radiation to treat wet age-related macular degeneration (AMD)
• Company 770 - An automated blood glucose monitor for the intensive care unit using near infra-red spectroscopy
• Company 771 - Human Globin, a biopolymer to replace animal collagens in dermal fillers and create biomaterials for tissue repair
• Company 772 - Indigo Orb, Inc is a technology leader in "Automatic Detection of Epidural Cavity"
• Company 773 - Developing and marketing EEG systems, tools and services for Neurologists, Neurosurgeons, and Neuroscience Researchers
• Company 774 - Orthopedic products, specifically for upper and lower extremity small bone applications
• Company 775 - Lumbar system for dynamic stabilization without fusion, artificial discs, and minimally invasive surgery systems
• Company 776 - Reintroducing CHYMOPAPAIN, the only proven minimally-invasive therapy for herniated discs; it allows nuclear regeneration.
• Company 777 - 1-Lumbar cage with integrated fixation screws, 2-Pedicle screw product line, 3-Access systems and implants for use in minimally invasive surgery (MIS)
• Company 778 - Water-resistant adhesives derived from mussels, used as tissue adhesives/anti-bacterial coatings
• Company 779 - Revisable cervical and lumbar total disc replacement that can be converted to fusion
• Company 780 - Motion preservative artificial disc
• Company 781 - Disc Motion Technologies has developed the first posterior lumbar arthroplasty system consisting of an artificial lumbar disc and a posterior dynamic stabilizer.
• Company 782 - Building on an exclusive intellectual property platform for both fusion and non-fusion products
• Company 783 - Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.
• Company 784 - Spinal implants, cervical, thoracolumbar, interbody, bone substitutes, motion preservation
• Company 785 - Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic biomaterials
• Company 786 - Wireless patient vital signs monitoring
• Company 787 - Disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker
• Company 788 - 1-Soft tissue attachment nanotechnology, 2-Bioactive/biocompatible/osteoconductive synthetic bone filler, 3-Biodegradable fiberglass fiber & composites
• Company 789 - Noninvasive blood glucose monitor that will measure glucose in sweat in a disposable dermal patch
• Company 790 - Affordable thermal systems that are portable, easy-to-use, and comfortable to wear
• Company 791 - High Intensity Focused Ultrasound for incisionless male surgical sterilization
• Company 792 - Ambulatory infusion pumps and disposables that require no programming and use pre-filled solution containers
• Company 793 - ViaDerm- home use transdermal drug delivery system creating microscopic passageways in the top skin layer
• Company 794 - Tools for enabling adult stem cell based regenerative medicine
• Company 795 - Lectin-based cell adhesion technology which enables stents that traffic cells in the bloodstream
• Company 796 - Programmable lab-on-a-chip platform for applications ranging from drug discovery to consumer diagnostics
• Company 797 - Technology that enables real-time tracking of the position and orientation of any interventional tool (biopsy device, catheter, endoscope, ablation probe, marker dispenser, etc.)
• Company 798 - Blood tests for: breast cancer/Alzheimer¥' s disease/women¥' s cancers
• Company 799 - Spinal implants utilizing elastomeric polymers for non-fusion treatment of disc degeneration
• Company 800 - ECG software for assessing acute ischemia and cardiac safety surrogates in clinical trials
• Company 801 - Resorbable pegylated hydrogel for surgical wound sealing/adhesion prevention/sustained and targeted drug delivery
• Company 802 - The Sensation
• Company 803 - Robot-assisted stroke therapy devices
• Company 804 - Endothelial management- less trauma combined with new agents for improved healing in vascular interventions
• Company 805 - Digital Pulse Analyzer- provides early detection of arterial wall stiffness and biological age of arteries
• Company 806 - Diagnostic platform with a test for measuring unbound Bilirubin for the management of newborn jaundice
• Company 807 - Percutaneous light activation reduces intra-abdominal fat, returning Type 2 diabetic patients towards normoglycemia
• Company 808 - 1-Cartilage implant for the knee, 2-Injectable cell therapy for the spinal disc/nucleus, 3-Bone graft extender to treat spinal deformities
• Company 809 - Protein free induction of endochondral ossification, no human origin, not contagious, no soft tissue ossification
• Company 810 - 1-Instant-on/instant-off proximal occlusion funnel catheter, 2-Scoring balloon with drug delivery capability
• Company 811 - An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiovascular surgery
• Company 812 - Technology that prepares the spinal disc for a nucleus replacement/minimally invasive fusion device
• Company 813 - Tissue repair devices exploiting shear force transfer and large-interface substrates for adherent new tissue formation
• Company 814 - Advanced skin biopsy and wound healing solutions to dermatology, cosmetic, primary care, and oncology clinicians
• Company 815 - Advanced optical systems/services that are changing the way doctors evaluate and treat the eye
• Company 816 - Non-invasive cardiac output monitoring to assess stroke volume, contractility, cardiac output, cardiac index, and thoracic fluid content
• Company 817 - 1-Cardiovascular-directed growth factor therapeutics; 2-Endovascular catheter-based system to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events
• Company 818 - A drug delivery platform that approaches the endovascular bifurcation challenge from a completely different angle
• Company 819 - A bioactive ceramic that delivers better/faster spine fusion and bone repair
• Company 820 - Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure
• Company 821 - Next-generation biomaterials technology
• Company 822 - Noninvasive medical device for the treatment and prevention of obesity using controlled hypoxia
• Company 823 - An implantable ophthalmic device to treat vision correction associated with Age-Related Macular Degeneration (AMD)
• Company 824 - Accommodating and multifocal phakic IOLs, CE-approved for $ billion refractive IOL market
• Company 825 - Biocompatible polymer implant to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation
• Company 826 - Noninvasive device used in the differential diagnosis of disc or facet mediated low back pain
• Company 827 - Surgical stapling devices for open and laparoscopic procedures developed for the growing China market
• Company 828 - PowerCosmetics micro-electronic patches, delivering skincare results faster and more effectively
• Company 829 - IBraces- 100% customized, invisible orthodontic braces designed for efficient, effective treatment of teens and adults
• Company 830 - Flash Ultrasound
• Company 831 - Free-floating optical probe with multiple LD scanning and magnetic stabilization for noninvasive blood glucose monitoring
• Company 832 - Repositionable/removable percutaneous heart valve, precision controlled delivery device, and calcified valve encapsulation system
• Company 833 - Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device
• Company 834 - Heart pump that achieves superior flow and pressure performance, mimicking the physiological performance of the human heart, and reducing post-surgery kidney failure, mortality, and complications cost by 50%
• Company 835 - Porcine-derived tissue devices for ligament, cartilage, bone, and soft tissue replacement and augmentation
• Company 836 - MIS platform technologies for creating cavities in tissue and partially molding an orthopedic implant in situ
• Company 837 - Orbital atherectomy for the treatment of peripheral vascular disease
• Company 838 - Functional brain imaging centers that identify Alzheimer' s, brain injury, stroke, ADHD, bipolar, depression, anxiety, OCD
• Company 839 - A protein therapeutic biotreatment that regresses solid tumors and protects against relapses
• Company 840 - Analyze, search, store, mine, share and unlock the power of digital tissue images
• Company 841 - Smart devices to harness human physiology for health care, industrial safety, and law enforcement applications
• Company 842 - Naturally-derived/non-crosslinked/collagen-based extracellular matrix to repair/remodel damaged tissues
• Company 843 - Facet fixation system that is a less-invasive/faster alternative to pedicle screw fixation
• Company 844 - Catheter-based technology for orthopedic trauma indications providing site-specific tissue drainage and drug delivery
• Company 845 - Shielded reciprocating tissue sculpturing instrument, able to navigate into neural foramen to relieve nerve compression
• Company 846 - 1-LIFEBACKR Spine Programs for non-operative and post-operative spine patients and 2-the LTX 3000R Rehabilitation System
• Company 847 - Stable and extractable self locking intramedullary nails and proximal femoral fixation
• Company 848 - Emperor Mobile Spinal Disc, P.E.E.K Cages, Pedicle Screw System, and Saturn Hip Resurfacing
• Company 849 - Rapid table-mounted retraction/surgical site access for MIS placement of hip/knee/shoulder/spine implants
• Company 850 - Lumbar dynamic stabilization with MIS compatibility and pedicle screws
• Company 851 - Real-time image-guidance technology with an FDA-accepted accuracy claim of +/-1mm at 1 meter
• Company 852 - Noninvasive, ambulatory, portable, 3-D traction technology providing an effective and unique therapy for spinal disorders
• Company 853 - Fusion technology platforms and second-generation artificial discs for the lumbar and cervical spine
• Company 854 - A biological and mechanical solution to annular repair and spine fusion
• Company 855 - Low-profile implants/less invasive surgical instruments to treat spinal disorders utilizing fusion and non-fusion technologies
• Company 856 - A CE-marked resorbable plating system for cervical fusions allowing for load sharing
• Company 857 - Biomaterials-based product that augments or replaces the diseased nucleus pulposus of the spinal disc
• Company 858 - Nitric oxide-based therapies to accelerate healing of tendon, bone, and other musculoskeletal tissue
• Company 859 - Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
• Company 860 - Synthetic bone that duplicates the microstructure, composition, and performance of human bone
• Company 861 - Implanted oscillating field stimulation device which regenerates acute and sub-acute damaged spinal cord nerve tissue
• Company 862 - PuraMatrix injectable synthetic nanofibrous hydrogels for bone, cartilage and soft tissue regeneration, and drug delivery
• Company 863 - Noninvasive device providing substitute vestibular sensory information through the tongue for treatment of balance disorders
• Company 864 - Naturally occurring neuropeptide to treat ischemia associated with myocardial infarction, heart failure, and angina
• Company 865 - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients suffering urinary retention
• Company 866 - Phase-shifting technology for Contrast Ultrasound imaging
• Company 867 - Medical devices, utilizing robust tyrosine-based resorbable polymer systems/pharmaceuticals in surgical barriers/cardiac rhythm management
• Company 868 - Laparoscopic surgical access technology based on a No-Seal platform
• Company 869 - Theramers
• Company 870 - Respiratory diagnostics for noninvasive assessment of airway acidification in Asthma, COPD, and GERD
• Company 871 - A "preventative" vaccine for HIV-AIDs
• Company 872 - Post-proteomics multiplexed MS-based diagnostics/theranostics linked to drug development and personalized medicine
• Company 873 - Image-guided therapy for metastatic liver disease
• Company 874 - Biomaterial that regulates resorbability and enhances bone regeneration
• Company 875 - Drug/device products for post-operative pain and orthopedic drug delivery indications using syntinate synthetic absorbables
• Company 876 - Ultrasonic medical devices for minimally invasive therapeutic procedures for treatment of cancer/other healthcare purposes
• Company 877 - Multi-channel implantable microelectrodes for deep brain stimulation and recording, enabling enhanced neuromodulation therapies
• Company 878 - Aesthetic treatment device using collimated high-energy light and laser, delivered simultaneously by fiber delivery system
• Company 879 - A remotely controlled, wireless-powered implantable 230-channel nerve stimulator built on a 15
• Company 880 - Real-time, noninvasive monitoring of blood loss, anemia, and other vital blood measurements
• Company 881 - Small/portable/handheld device for diagnosing brain hematomas
• Company 882 - Fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify lipid rich plaques in the coronary arteries
• Company 883 - Laparoscopic surgeons maintain direct control of the laparoscope movement/placement with GMP' s Laparocision
• Company 884 - Rapid testing systems led by the Growth Direct
• Company 885 - Noninvasive mechanical compression for treatment/prophylaxis of lower extremity circulatory disorders such as: PAD/DVT
• Company 886 - Ultraviolet light technologies for the inactivation of RNA viruses in/out of the body
• Company 887 - Minimally invasive percutaneous neuromodulation pain therapy
• Company 888 - The Axya Shoulder Fixation System generates ultrasonic energy for knotless suture welding in shoulder surgery
• Company 889 - Gene-based products for the diagnosis and treatment of spinal disorders
• Company 890 - A platform aerosol drug delivery nebulizer device for multiple- and single-use applications with disposables
• Company 891 - Non-invasive continuous measurement of tissue oxygenation for various intraoperative and post-operative applications
• Company 892 - Vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis
• Company 893 - Next-generation bio-medical adhesive, used as a filler for aneurysms in various areas of the body
• Company 894 - SurfLink
• Company 895 - Bifurcated coronary stent
• Company 896 - Microsensors and receptors for the real-time measurement of therapeutic drugs and clinical chemistry parameters
• Company 897 - Noninvasive, outpatient bariatric device for overweight/obesity
• Company 898 - A suite of tools for automated CT Angiography (CTA) diagnostics for Coronary Artery Disease
• Company 899 - Magnetically actuated telescopic intramedullary (IM) nail activated by an induced low power directional magnetic field
• Company 900 - Transdermal delivery system of levodopa (L-DOPA) for the treatment of Parkinson' s Disease
• Company 901 - Immediate, active, device-less, and painless topical drug delivery, of small/macromolecules, for local/systemic indications
• Company 902 - Endotracheal tube with video, self-locking orthopedic implants, structured TPN lipids, cell therapy for cancer, etc.
• Company 903 - Products that digitize manual breast examination tissue elastic properties into objective computerized visual maps/reports
• Company 904 - Technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue
• Company 905 - Non-invasive airway clearance in ICU patients to prevent ventilator associated pneumonia
• Company 906 - Unique add on and removable needle safety product that fits to standard glass/plastic syringes
• Company 907 - Medical devices utilizing radiofrequency and microwave energy which are cost-effective and clinically relevant
• Company 908 - Non-invasive screening of Peripheral Arterial Disease (PAD), combining postural/infrared blood volume testing
• Company 909 - Tissue fixation implants, injectable bone grafting biomaterials, and tissue scaffolds with drug releasing properties
• Company 910 - Miniature implantable, continuous blood glucose sensor for diabetics, incorporating noninvasive wireless monitoring
• Company 911 - Coronary guidewire, to provide real-time ultrasonic measurement of coronary arteries to determine stent size and apposition without exchange of catheters
• Company 912 - Bioabsorbable, bioactive, and drug-releasing medical device products for various fields of surgery
• Company 913 - 1- Interventional single-use cardiac support device and drug delivery platform, 2- Implants for use in/with magnetic resonance imaging (MRI) systems
• Company 914 - Endoscopically-placed devices to prevent GERD, obesity, and irritable bowel syndrome (IBS)
• Company 915 - Cellular implants for orthopedic, trauma, and spinal applications based on a biological form stable matrix
• Company 916 - SmartStep
• Company 917 - Dynamic optimization of pacing intervals according to hemodynamic sensors for CRT devices
• Company 918 - Expert systems and miniaturized hardware for stroke prevention and management and for pre-operative brain protection
• Company 919 - Medical devices that enable diabetes disease management and the prevention of lower extremity amputations
• Company 920 - Customized miniature disposable stereoscopic cameras that provide 3D vision, measurements, and image fusion in real-time
• Company 921 - Infusion catheter for treatment of tumors which are unresponsive to systemic chemotherapy by the local delivery of drugs and other agents
• Company 922 - 3-D tomographic ultrasound imaging system to aid in diagnosing breast cancer
• Company 923 - RFID hardware and software platform for test tubes/ apheresis device for blood component separation
• Company 924 - Saliva-based consumer diagnostic systems, which enable the development of personalized therapeutics
• Company 925 - Disposable, noninvasive, pump-less, and valve-less automatic blood pressure monitor "on-a-chip"
• Company 926 - Noninvasive neural vision enhancement
• Company 927 - Nanotechnologies for use in orthopedic implants, dental implants, and stents
• Company 928 - Specialty and standard electrophysiology catheters that have superior performance, advantageous features, and are affordable
• Company 929 - Dedicated angioplasty and stent systems for the treatment of arterial bifurcations
• Company 930 - System to ablate cardiac tissue as a means to potentially treat atrial fibrillation
• Company 931 - Point-of-care IVD platform that provides rapid, accurate, automated laboratory testing using low cost, disposable biochips
• Company 932 - Interventional MRI technology for cardiovascular imaging including detection/treatment of vulnerable plaque
• Company 933 - System analyzes a patient' s susceptibility to cardiac arrest and consequent need for implantable defibrillator
• Company 934 - Patient recovery system for cosmetic and reconstructive surgery
• Company 935 - Microscope slide scanners and information management software that enable the digitization of pathology
• Company 936 - SutureLock- a versatile suture-securing knot-replacement device for endoscopic wound approximation
• Company 937 - Multi-Sensing Wireless Catheter platform attached along the GI-Uro tract detecting GERD, incontinence, and other abnormalities
• Company 938 - Noninvasive medical device providing low-risk hypoxic treatment that induces appetite suppression and weight loss
• Company 939 - Minimally invasive telemetric and continuous measurement of left atrial blood pressure at heart failure
• Company 940 - Catheter-based photoreactive treatment system for endovascular intervention in coronary and peripheral atherosclerotic disease
• Company 941 - An approach using RF energy for shrinkage of the valve annulus to reduce/eliminate regurgitation
• Company 942 - A platelet reactivity test to measure the effect of anti-platelet drugs, particularly aspirin and Plavix
• Company 943 - OmniWave
• Company 944 - A portable laseroptical system for noninvasive differentiation between ischemic stroke and spontaneous intracerebral hemorrhages
• Company 945 - Alginate-based embolic material designed to fill blood vessel defects thereby displacing blood pressure effects and preventing vessel rupture
• Company 946 - A wearable continuous ultrafiltration device that removes fluid overload in patients with Congestive Heart Failure
• Company 947 - Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass
• Company 948 - Surgical and percutaneous cardiac valve repair
• Company 949 - Percutaneous mitral valve repair simulating precision of surgical annuloplasty
• Company 950 - Pressure and flow sensing systems for vascular and other applications
• Company 951 - Advanced ECG-heart sound analysis to enable superior diagnosis/monitoring of CHF/ACS patients
• Company 952 - Minimally invasive interventional radiology/vascular surgery devices
• Company 953 - PeriVasc
• Company 954 - Perfusion monitoring for preventing septic shock, the greatest hospital mortality
• Company 955 - A noninvasive test for endothelial dysfunction using digital (fingertip) thermal monitoring
• Company 956 - Stentless aortic valve prosthesis to be delivered via catheter
• Company 957 - Catheter-based therapy which increases cerebral perfusion for the treatment of ischemic stroke and vasospasm
• Company 958 - Catheter-based devices to reconstruct the ventricle and downsize the heart volume
• Company 959 - Noninvasive device using muscular counter pulsation (MCP) technology for the treatment of chronic heart failure (CHF)
• Company 960 - 1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Corresponding catheter for accurate transmyocardial injection
• Company 961 - Minimally invasive device-based technologies targeting the treatment of hemodynamic instability and perfusion
• Company 962 - Peptide-based therapeutic to enhance stent/graft patency
• Company 963 - Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet therapy
• Company 964 - Disposables for drawing blood -- percutaneous or from a catheter -- neonates to geriatrics
• Company 965 - Electrode sensor array, with integrated lead wires, simple, accurate and repeatable ECGs
• Company 966 - In vivo plasmapheresis and ultrafiltration to remove excess fluid from CHF patients in clinical trials
• Company 967 - Noninvasive therapeutic ultrasound to enhance perfusion for treatment of acute myocardial infarction
• Company 968 - Affordable handheld metabolic monitor (indirect calorimeter) with both medical and consumer weight management applications
• Company 969 - Unique microsphere-based technology for chronic/acute wounds
• Company 970 - Technologies that utilize flexible cross linking and sterilization processes which stabilize and sterilize biological tissue for use in orthopedic, wound, oral/dental, spine and neurological, breast, abdominal and thoracic applications
• Company 971 - Devices for mechanically induced bone growth, together with a "smart device" system for risk management
• Company 972 - Nitric oxide releasing surface treatments for enhanced biocompatibility in medical devices
• Company 973 - Automated implantable pump systems for moving fluids around inside the body
• Company 974 - Minimally invasive surgical access system used in laparoscopic surgery
• Company 975 - Long-term, miniature drug delivery implant with physician- controllable, zero-order release characteristics
• Company 976 - 1-Single-use, patented, disposable, hemorrhoid banding system; 2-Two-tier colon cancer diagnostic screen, Fecal Occult Blood Testing (FOBT)
• Company 977 - Interventional catheter-based system precisely measures stent and arterial size and cardiovascular repair tissue patch products
• Company 978 - Device for the treatment of mitral regurgitation and heart failure without requiring open heart surgery
• Company 979 - Light-based therapy for eradication of ulcer-causing Helicobacter pylori
• Company 980 - Non-invasive medical radar imaging for cardiopulmonary ambulatory monitoring and diagnosis
• Company 981 - Enteric Dialysis with Kibow Biotics- a food-grade microbial Gel cap formulation towards kidney failure applications
• Company 982 - IYIA has developed a proprietary, clinically effective device, O2Misly, for treating slow healing foot wounds, primarily diabetic foot ulcers
• Company 983 - Genetic and personal history based testing to predict age-specific risk of breast cancer diagnosis
• Company 984 - Controlled fluid delivery system for every medical application without batteries or power cords
• Company 985 - Non-contact intelligent medical vigilance for the hospital
• Company 986 - Capture and analysis of heart sounds leading to rapid and accurate diagnosis of cardiac pathologies
• Company 987 - Blood test that screens/diagnoses cervical cancer without need of a cervical exam/pap smear
• Company 988 - Implantable Left Ventricular Assist Device (LVAD) for heart failure
• Company 989 - Bioabsorbable drug eluting stents and stent coatings for treatment of vulnerable plaque and coronary stenosis
• Company 990 - Electronic pill for oral delivery of low bioavailability drugs
• Company 991 - Microsyringe delivery of cells, genes, and drugs to the vasculature/deep tissues of the body
• Company 992 - Percutaneous noninvasive heart valve replacement
• Company 993 - Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation
• Company 994 - Percutaneous access management system to provide early ambulation/eliminate major complications, leaving nothing behind in patient
• Company 995 - Totally implantable LVAD that does not interface with circulating blood
• Company 996 - Blood test for breast cancer measuring 5 protein biomarkers using super-sensitive ELISA with 95% accuracy
• Company 997 - Device for the treatment of Barrett' s esophagus and prevention of esophageal cancer
• Company 998 - A device for the left atrial appendage for stroke prevention in patients with atrial fibrillation
• Company 999 - Noninvasive monitor to measure exhaled nitric oxide for the management of asthma
• Company 1000 - Microplate-based electronic biosensor system for label-free, real-time cell based assays
• Company 1001 - Interactive intraoperative CT scanning technology for image-guided interventions
• Company 1002 - High Intensity Focused Ultrasound for minimally invasive thermal treatment of disc herniation without disc penetration
• Company 1003 - Percutaneous systems to treat lower back pain
• Company 1004 - Least invasive approach for the delivery of lumbar fusion and motion preservation therapies
• Company 1005 - Telemeterized natural motion elastomer disc
• Company 1006 - Interspinous process implant to treat Lumbar Spinal Stenosis (LSS)
• Company 1007 - Clinical expertise, facility development, new technology, and business services including marketing and contracting
• Company 1008 - Advance and commercialize less invasive spinal deformity surgical treatment without fusion
• Company 1009 - Lumbar, thoracic, and cervical fusion devices including less invasive instrumentation; lumbar and cervical artificial discs
• Company 1010 - Lumbar spine motion preservation via dynamic stabilization utilizing a semi-rigid rod and screw system
• Company 1011 - Nucleus replacement device
• Company 1012 - Compliant artificial lumbar disc with graduated modulus for restoration of normal spine biomechanics/enhanced durability
• Company 1013 - 1-Synthetic alternatives to autograft/cadaver-based bone material, 2-Surgical hemostat as an adherent matrix/impermeable barrier to blood flow, 3-Bone augmentation material for injections in osteoporotic spines to treat vertebral compression fractures
• Company 1014 - Orthopeutics, LP introduces Intrabrace a new non-surgical, injectable treatment for resisting spinal curvature in scoliosis.
• Company 1015 - Bioactive synthetic bone graft substitute that is osteostimulative, osteoconductive, antimicrobial, and hemostatic
• Company 1016 - Next-generation fusion, motion sparing, and minimally invasive spinal implant products
• Company 1017 - Minimally invasive fusion system
• Company 1018 - Fluidjet devices for open and MIS fusion, discectomy, artificial nucleus, and artificial disc procedures
• Company 1019 - Osteogenica- bone marrow concentration system
• Company 1020 - Dascor Arthroplasty System, spinal implants technology
• Company 1021 - BioDisc, a nucleus replacement product based on an injectable, flexible, and durable protein hydrogel technology
• Company 1022 - Second-generation, viscoelastic artificial disc restoring native function to the spine
• Company 1023 - Three-dimensional surgical visualization technologies and expanding portfolio for digital surgical environment and digital healthcare network
• Company 1024 - Real-time disposable stereotactic navigation devices for biopsy/targeted therapy compatible with CT, fluoroscopy, and MRI
• Company 1025 - Minimally invasive cancer therapy using Magnetically Energized (ME) Thermotherapy
• Company 1026 - Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals
• Company 1027 - First noninvasive, transcutaneous sensor array that continuously monitors peripheral circulation and/or core body temperature
• Company 1028 - Disposable balloon cervical dilator for improved uterine access that decreases pain, avoids tearing and perforations
• Company 1029 - Implantable encapsulated-cell technology for delivery of biological therapeutics to the nervous system
• Company 1030 - Complete pre-configured system for implementing minimized cardiopulmonary bypass
• Company 1031 - Catheter-based sealing of heart defects associated with stroke, migraine headaches, and other brain attacks
• Company 1032 - Technology for imaging peripheral nerves in regional anesthesiology, pain management, and other markets
• Company 1033 - Nanomagnetic particles enabling controlled drug delivery and elution for drug targeting and medical device applications
• Company 1034 - MRI-compatible, precision- guided laser therapy for the treatment of brain tumors
• Company 1035 - Implantable blood pump with magnetic levitation technology for patients suffering from heart failure
• Company 1036 - Virtual Bone Biopsy MRI scanner add-on, allowing noninvasive imaging of bone microstructure for osteoporosis monitoring
• Company 1037 - Precise miniature robotic technology for spine, knee, orthopedic, and neurosurgery minimally invasive procedures- SmartAssist
• Company 1038 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific nano-particles, adaptable to all solid tumors
• Company 1039 - Point-of-care platform technology for assessing risk of cardiovascular disease and renal dysfunction
• Company 1040 - Continuous blood gas monitoring and cardiac output measurement for the intensive care unit
• Company 1041 - Non-blood contacting, active implantable direct cardiac compression device for the treatment of CHF
• Company 1042 - Augmented reality simulators that train surgeons in the skills required for minimally invasive surgery
• Company 1043 - Continuous, non-invasive glucose monitor for tight glycemic control at the hospital and at home
• Company 1044 - ERBLAN MIS Surgical Devices allow safe entry into virtually any actual or potential anatomical space
• Company 1045 - Technology that non-invasively measures/monitors mechanical heart function and disease utilizing a disposable brachial cuff
• Company 1046 - Endovenous ablation system for varicose veins with 1320 nm CoolTouch laser
• Company 1047 - Micro-porous ceramic wound treatment device that creates optimal conditions for normal wound healing
• Company 1048 - Direct, real-time vision through flowing blood to guide therapy inside the heart and vessels
• Company 1049 - Cath lab solution providing rapid onset of circulatory support in patients with acute heart failure
• Company 1050 - Magnesium-based compound that will attach bone to bone and ligaments and tendons to bone
• Company 1051 - AepEX auditory evoked potential depth of anesthesia monitor and aepEX-Fusion servo-controlled anesthesia delivery system
• Company 1052 - Posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion
• Company 1053 - Site-specific biological and drug delivery
• Company 1054 - Noninvasive ultrasound-based tissue analysis services for early detection of malignant tumors
• Company 1055 - Non-irritating dry electrodes now enabling long-term cardiac monitoring
• Company 1056 - Non-incisional female sterilization
• Company 1057 - Biopharmaceuticals targeting osteo-renal indications, including the complications of chronic kidney disease and dialysis, bone and cartilage repair and regeneration, and general dental and oral care
• Company 1058 - Portable, compact, easy-to-use automated external defibrillators with full energy delivery and complete resuscitation solutions
• Company 1059 - Rapid, point-of-care in vitro diagnostics
• Company 1060 - Endoscopy systems allowing physicians to see very small, early-stage cancer and subtle pre-cancerous lesions
• Company 1061 - Surgical instruments employing thermal welding technology to seal and cut tissue
• Company 1062 - Minimally invasive disc replacement for chronic back pain
• Company 1063 - A smart, communicating cigarette case, online support, and daily e-mails delivering an effective stop-smoking method
• Company 1064 - A wireless personal emergency alert system that integrates with, and enhances, existing implanted medical devices
• Company 1065 - Artificial total intervertebral disc capable of normal physiological movement and weight loading
• Company 1066 - Catheters designed to diagnose, terminate, and treat cardiac arrhythmia during EP and ablation procedures
• Company 1067 - Conservative Motion Preservation technology including minimally invasive facet joint replacement
• Company 1068 - BioSilicon, nano-structured porous silicon for applications in drug delivery, diagnostics, tissue engineering, and orthopedics
• Company 1069 - System that prevents embolic events by removing plaque and thrombus found in diseased arteries
• Company 1070 - Bioresorbable polymer implants for use in a variety of orthopedics and spine surgical applications
• Company 1071 - Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant
• Company 1072 - Helical stent providing enhanced abilities and flexibilities in drug delivery, scaffolding, and embolic protection
• Company 1073 - Trabectome, an FDA-cleared, minimally invasive medical device technology for the treatment of open angel glaucoma
• Company 1074 - A wireless, early detection and auto-alerting heart monitor system for outpatient and homecare markets
• Company 1075 - Prevention of scarring caused by disease, medical intervention, or trauma via a beta emitting biopolymer
• Company 1076 - Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye
• Company 1077 - Real-time, CT-guided, robotically controlled needle drivers for minimally invasive cancer therapy
• Company 1078 - Automated, continual blood glucose monitoring for critically ill patients
• Company 1079 - Molecular diagnostics based on patented, standardized, next-generation, multi-gene expression (StaRT-PCR) products and high margin services
• Company 1080 - THERMOCEPS- a handheld, wireless device that stops bleeding during surgical procedures using focused, thermal coagulation
• Company 1081 - Interventional catheter system for the mechanical recanalization of arterial chronic total occlusions quickly and reliably
• Company 1082 - Portable automated critical care neuro instruments using advanced digital signal processing technology
• Company 1083 - Monitor for autonomic nervous system displaying sympathovagal balance in real-time for diabetes/ anesthesia/cardiology applications
• Company 1084 - Branched endografts for aortic disease
• Company 1085 - Next-generation biomaterials using bioactive-ceramics technology platform
• Company 1086 - Immunodiagnostics of placental recombinant markers to screen the risk of preeclampsia, preterm delivery, and IUGR
• Company 1087 - Methods for eyebrow lifting, non-thermal loading of degradable matrices, and degradable implants
• Company 1088 - Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy
• Company 1089 - Minimally invasive needle biosensor for in vivo glucose or lactate monitoring of intensive care patients
• Company 1090 - P-15: a small peptide attachment factor for bone formation in orthopedics
• Company 1091 - MIST Therapy using non-contact ultrasound to stimulate healthy cells allowing chronic wounds to heal
• Company 1092 - Arthroscopic surgical devices
• Company 1093 - Electronic device that closes the gap between drugs and surgery in osteoarthritis of the knee
• Company 1094 - Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction
• Company 1095 - A five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function
• Company 1096 - Devices delivering infrared light to reduce pain and accelerate tissue healing
• Company 1097 - Next-generation non-vascular interventional pulmonary and gastrointestinal stenting technology
• Company 1098 - Artificial lung delivers O2 and removes CO2 through a catheter inserted into the vena cava
• Company 1099 - Intravascular temperature management systems and catheters for cardiac and neuro intensive care patients
• Company 1100 - Implantable devices for the endovascular treatment of hemorrhagic stroke
• Company 1101 - Ultrasound catheters for targeted thermal ablation of tumors

Related Reports